Oxidative stress: free radical production in neural degeneration.

[1]  J Carter,et al.  Molecular Pathology of Alzheimer's Disease , 2013 .

[2]  B. Bowman.  Acetyl-carnitine and Alzheimer's disease. , 2009, Nutrition reviews.

[3]  H. Ganther,et al.  Selenium: biochemical role as a component of glutathione peroxidase. , 2009, Science.

[4]  E. Stadtman.  Protein oxidation and aging , 2006, Science.

[5]  J. Walker,et al.  Structural comparisons of superoxide dismutases. , 2005, European journal of biochemistry.

[6]  D. Harman.  Free‐Radical Theory of Aging , 1992, Mutation research.

[7]  S. LeVine,et al.  The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. , 1996, Brain research. Developmental brain research.

[8]  P. Riederer,et al.  The thiobarbituric acid assay reflects susceptibility to oxygen induced lipid peroxidation in vitro rather than levels of lipid hydroperoxides in vivo: A methodological approach , 1993, Neurochemistry International.

[9]  M. Brin,et al.  Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. , 1993, The New England journal of medicine.

[10]  B. Mcdonald,et al.  Absence of aluminium in neuritic plaque cores in Alzheimer's disease , 1992, Nature.

[11]  J. Shih,et al.  Promoter organization and activity of human monoamine oxidase (MAO) A and B genes , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  K. Kristensson,et al.  Lipid Composition in Different Regions of the Brain in Alzheimer's Disease/Senile Dementia of Alzheimer's Type , 1992, Journal of neurochemistry.

[13]  D. Murphy,et al.  Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP+. , 1992, Free radical biology & medicine.

[14]  B. S. Winkler.  Unequivocal evidence in support of the nonenzymatic redox coupling between glutathione/glutathione disulfide and ascorbic acid/dehydroascorbic acid. , 1992, Biochimica et biophysica acta.

[15]  C. W. Olanow,et al.  Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.

[16]  C. Morris,et al.  Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. , 1992, The Biochemical journal.

[17]  P. Mcgeer,et al.  Accumulation of amyloid precursor protein in damaged neuronal processes and microglia following intracerebral administration of aluminum salts , 1992, Brain Research.

[18]  E. Morgan,et al.  Iron and transferrrin uptake by brain and cerebrospinal fluid in the rat , 1992, Brain Research.

[19]  M. Kadiiska,et al.  In vivo evidence of hydroxyl radical formation after acute copper and ascorbic acid intake: electron spin resonance spin-trapping investigation. , 1992, Molecular pharmacology.

[20]  A. Bindoli,et al.  Biochemical and toxicological properties of the oxidation products of catecholamines. , 1992, Free radical biology & medicine.

[21]  W. Johnson,et al.  Hereditary Lewy‐Body Parkinsonism and Evidence for a Genetic Etiology of Parkinson's Disease , 1992, Brain pathology.

[22]  B. Ames,et al.  Protein oxidation associated with aging is reduced by dietary restriction of protein or calories. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  N. Guo,et al.  Characterization and localization of glutathione binding sites on cultured astrocytes. , 1992, Brain research. Molecular brain research.

[24]  T. Paraidathathu,et al.  Production of reactive oxygen by mitochondria from normoxic and hypoxic rat heart tissue. , 1992, Free radical biology & medicine.

[25]  J. Gilbert,et al.  Isolation of a cytochrome oxidase gene overexpressed in Alzheimer's disease brain , 1992, Molecular and Cellular Neuroscience.

[26]  A. Davison,et al.  Protection by beta-carotene and related compounds against oxygen-mediated cytotoxicity and genotoxicity: implications for carcinogenesis and anticarcinogenesis. , 1992, Free radical biology & medicine.

[27]  Y. Nishizuka.  Signal transduction: crosstalk. , 1992, Trends in biochemical sciences.

[28]  C. Marsden,et al.  α‐tocopherol levels in brain are not altered in Parkinson's disease , 1992 .

[29]  S. Shankar,et al.  Microsomal cytochrome P450 in human brain regions. , 1992, Biochemical pharmacology.

[30]  M. Matsuoka,et al.  Preservation of energy metabolites by carnitine in the mouse brain under ischemia , 1992, Brain Research.

[31]  Brian J Cummings,et al.  Gliotoxic actions of excitatory amino acids , 1992, Neuropharmacology.

[32]  S. Markey,et al.  A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  K. Jellinger,et al.  Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.

[34]  L. Loeb,et al.  DNA damage and repair in brain: relationship to aging. , 1992, Mutation research.

[35]  R. S. Sohal,et al.  Mitochondrial production of pro-oxidants and cellular senescence. , 1992, Mutation research.

[36]  C. Cotman,et al.  Hippocampal excitatory amino acid receptors in elderly, normal individuals and those with Alzheimer's disease: Non-N-methyl-d-aspartate receptors , 1992, Neuroscience.

[37]  J. Knoll.  Pharmacological basis of the therapeutic effect of (−)deprenyl in age‐related neurological diseases , 1992, Medicinal research reviews.

[38]  G. Willis,et al.  Amine accumulation: a possible precursor of Lewy body formation in Parkinson's disease. , 1992, The International journal of neuroscience.

[39]  R. S. Sohal,et al.  A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. , 1992, Mutation research.

[40]  H. Bernstein,et al.  Oxidative and other DNA damages as the basis of aging: a review. , 1992, Mutation research.

[41]  R. Rosenthal,et al.  Prevention of Postischemic Canine Neurological Injury Through Potentiation of Brain Energy Metabolism by Acetyl‐L‐Carnitine , 1992, Stroke.

[42]  C. Richter,et al.  Reactive oxygen and DNA damage in mitochondria. , 1992, Mutation research.

[43]  J. Cooper,et al.  Mitochondrial function in neurodegeneration and ageing. , 1992, Mutation research.

[44]  Y. Agid,et al.  Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content? , 1992, Journal of neurochemistry.

[45]  D. Harman.  Free radical theory of aging. , 1992, Triangle; the Sandoz journal of medical science.

[46]  K. Jellinger,et al.  Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease , 1992, Neuroscience Letters.

[47]  G. Taglialatela,et al.  Stimulation of nerve growth factor receptors in PC12 by acetyl-L-carnitine. , 1992, Biochemical pharmacology.

[48]  K. Baimbridge,et al.  Calcium-binding proteins in the nervous system , 1992, Trends in Neurosciences.

[49]  S. Aquilonius,et al.  Monoamine oxidase-B in motor cortex: Changes in amyotrophic lateral sclerosis , 1992, Neuroscience.

[50]  E. Neafsey,et al.  Novel S‐Adenosylmethionine‐Dependent Indole‐N‐Methylation of β‐Carbolines in Brain Particulate Fractions , 1992, Journal of neurochemistry.

[51]  H. Mcardle.  The transport of iron and copper across the cell membrane: different mechanisms for different metals? , 1992, Proceedings of the Nutrition Society.

[52]  S. Salamat,et al.  Alzheimer's disease. Beta-amyloid precursor protein expression in the nucleus basalis of Meynert. , 1992, The American journal of pathology.

[53]  G. Forloni,et al.  Culture of dorsal root ganglion neurons from aged rats: Effects of acetyl-l-carnitine and NGF , 1992, International Journal of Developmental Neuroscience.

[54]  E. Neafsey,et al.  Mono‐N‐Methylation of 1,2,3,4‐Tetrahydro‐β‐Carbolines in Brain Cytosol: Absence of Indole Methylation , 1992, Journal of neurochemistry.

[55]  B. Halliwell,et al.  Biologically relevant metal ion‐dependent hydroxyl radical generation An update , 1992, FEBS letters.

[56]  J. Dowson,et al.  The morphology of lipopigment in rat Purkenje neurons after chronic acetyl-l-carnitine administration: A reduction in aging-related changes , 1992, Biological Psychiatry.

[57]  J. Trojanowski,et al.  Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease , 1992, Brain Research.

[58]  C. Morris,et al.  Uptake and Distribution of Iron and Transferrin in the Adult Rat Brain , 1992, Journal of neurochemistry.

[59]  R. Wurtman,et al.  Enhancement by Cytidine of Membrane Phospholipid Synthesis , 1992, Journal of neurochemistry.

[60]  C. Heizmann,et al.  Changes in Ca2+-binding proteins in human neurodegenerative disorders , 1992, Trends in Neurosciences.

[61]  P. Sandercock,et al.  The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[62]  I. Shoulson,et al.  An interim report of the effect of selegiline (L-deprenyl) on the progression of disability in early Parkinson's disease. The Parkinson Study Group. , 1992, European neurology.

[63]  Y. Agid,et al.  Toxic Effects of Iron for Cultured Mesencephalic Dopaminergic Neurons Derived from Rat Embryonic Brains , 1992, Journal of neurochemistry.

[64]  R. Lindsay,et al.  Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System , 1992, Journal of neurochemistry.

[65]  A. Torroni,et al.  Mitochondrial oxidative phosphorylation defects in Parkinson's disease , 1992, Annals of neurology.

[66]  P. Riederer,et al.  The molecular pharmacology of L-deprenyl. , 1992, European journal of pharmacology.

[67]  M. Carrillo,et al.  (−)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: The sex and age-related differences in the optimal dose in the rat , 1992, Experimental Neurology.

[68]  E. Hall,et al.  Tirilazad Mesylate Protects Vitamins C and E in Brain Ischemia‐Reperfusion Injury , 1992, Journal of neurochemistry.

[69]  N. Krinsky.  Mechanism of Action of Biological Antioxidants , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[70]  S. Mahadik,et al.  Loss and recovery of activities of α+ and α isozymes of (Na+ + K+)‐ATPase in cortical focal ischemia: GM1 ganglioside protects plasma membrane structure and function , 1992 .

[71]  K. Chowdhury,et al.  Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture , 1992, Neuroreport.

[72]  Y. Mizuno,et al.  Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain , 1992, Journal of the Neurological Sciences.

[73]  R. Wurtman,et al.  Effects of orally administered cytidine 5'-diphosphate choline on brain phospholipid content. , 1992, The Journal of nutritional biochemistry.

[74]  S. Bondy,et al.  Oxidative damage and cerebral aging , 1992, Progress in Neurobiology.

[75]  J. Valenzuela,et al.  Carotenoids as Cellular Antioxidants , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[76]  W. Gibb,et al.  Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease , 1992, Brain Research.

[77]  A. Davenport,et al.  Aluminium and dementia , 1992, The Lancet.

[78]  D. D. Di Monte,et al.  Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes. , 1992, Archives of biochemistry and biophysics.

[79]  J. Schneider,et al.  Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment. , 1992, Science.

[80]  O. Pastoris,et al.  The mitochondrial electron transfer alteration as a factor involved in the brain aging , 1992, Neurobiology of Aging.

[81]  E. Neafsey,et al.  Inhibition of mitochondrial succinate oxidation--similarities and differences between N-methylated beta-carbolines and MPP+. , 1992, Archives of biochemistry and biophysics.

[82]  J. Saura,et al.  Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19- 6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[83]  D. Wallace.  Mitochondrial genetics: a paradigm for aging and degenerative diseases? , 1992, Science.

[84]  J. Knoll.  The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: a personal view. , 1992, Pharmacology & toxicology.

[85]  N. Vermeulen,et al.  Monitoring of oxidative free radical damage in vivo: analytical aspects. , 1992, Chemico-biological interactions.

[86]  F. Jiménez-Jiménez,et al.  Serum levels of alpha‐tocopherol (vitamin E) in Parkinson's disease , 1992, Neurology.

[87]  Matthias M. Strittmatter,et al.  Parkinson's disease and dementia: clinical and neurochemical correlations. , 1992, Neuroreport.

[88]  J. Idle,et al.  Mutant debrisoquine hydroxylation genes in Parkinson's disease , 1992, The Lancet.

[89]  P. Mcgeer,et al.  Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine. , 1992, The American journal of pathology.

[90]  R. Wurtman.  Choline metabolism as a basis for the selective vulnerability of cholinergic neurons , 1992, Trends in Neurosciences.

[91]  I. Kola,et al.  Cu/Zn superoxide dismutase mRNA and enzyme activity, and susceptibility to lipid peroxidation, increases with aging in murine brains. , 1992, Brain research. Molecular brain research.

[92]  C. Marsden,et al.  Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. , 1992, Brain : a journal of neurology.

[93]  C. Olanow,et al.  Iron induces degeneration of nigrostriatal neurons , 1992, Brain Research Bulletin.

[94]  J. Talan-Hranilović,et al.  Cortical distribution of gangliosides in Alzheimer's disease , 1992, Neurochemistry International.

[95]  Ž. Vukelić,et al.  Gangliosides in the human brain development and aging , 1992, Neurochemistry International.

[96]  C. Olanow,et al.  Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms? , 1992, Neurology.

[97]  L. Ernster,et al.  The mode of action of lipid-soluble antioxidants in biological membranes: relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. , 1992, BioFactors.

[98]  S. Markey,et al.  Search for neurotoxins structurally related to 1-methyl-4-phenylpyridine (MPP+) in the pathogenesis of Parkinson's disease , 1992, Brain Research.

[99]  A. Møller.  Mean volume of pigmented neurons in the substantia nigra in Parkinson's disease , 1992, Acta neurologica Scandinavica. Supplementum.

[100]  E. Melamed.  Biochemical and functional differences between dopamine formed from endogenous tyrosine and exogenous L-dopa in nigrostriatal dopaminergic neurons , 1992, Neurochemistry International.

[101]  D. Perl,et al.  Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study , 1992, Annals of neurology.

[102]  J. Cooper,et al.  Quantitation of a mitochondrial DNA deletion in Parkinson's disease , 1992, FEBS letters.

[103]  D. Calne.  The nature of Parkinson's disease , 1992, Neurochemistry International.

[104]  R. J. Coleman.  Current Drug Therapy for Parkinson’s Disease , 1992 .

[105]  V. Petruzzella,et al.  In vivo effect of acetyl-L-carnitine on succinate oxidation, adenine nucleotide pool and lipid composition of synaptic and non-synaptic mitochondria from cerebral hemispheres of senescent rats. , 1992, Archives of gerontology and geriatrics.

[106]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[107]  J. Growdon,et al.  Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[108]  K. Blennow,et al.  Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease , 1992, Neurobiology of Aging.

[109]  H. Robertson.  Synergistic Interactions of D1- and D2-Selective Dopamine Agonists in Animal Models for Parkinson’s Disease: Sites of Action and Implications for the Pathogenesis of Dyskinesias , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[110]  C. Olanow.  A Rationale for Dopamine Agonists as Primary Therapy for Parkinson’s Disease , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[111]  J. Penney,et al.  Glutamate receptors in the substantia nigra of Parkinson's disease brains , 1992, Neurology.

[112]  R. Nixon,et al.  Aluminum Alters the Electrophoretic Properties of Neurofilament Proteins: Role of Phosphorylation State , 1992, Journal of neurochemistry.

[113]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[114]  S. Gauthier,et al.  Sustained Release Antiparkinson Agents: Controlled Release Levodopa , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[115]  J. Connor,et al.  Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease , 1992, Journal of neuroscience research.

[116]  J. Kornhuber,et al.  Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia. , 1992, Arzneimittel-Forschung.

[117]  P. Salo,et al.  Deprenyl reduces the death of motoneurons caused by axotomy , 1992, Journal of neuroscience research.

[118]  S. Kish,et al.  Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease , 1992, Journal of neurochemistry.

[119]  A. Eisen,et al.  Amyotrophic Lateral Sclerosis, Parkinson’s Disease and Alzheimer’s Disease: Phylogenetic Disorders of the Human Neocortex Sharing Many Characteristics , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[120]  D. Yin.  Lipofuscin-like fluorophores can result from reactions between oxidized ascorbic acid and glutamine. Carbonyl-protein cross-linking may represent a common reaction in oxygen radical and glycosylation-related ageing processes , 1992, Mechanisms of Ageing and Development.

[121]  J. Penney,et al.  Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study , 1992, Neuroscience.

[122]  S. Horai,et al.  Is Parkinson's disease a mitochondrial disorder? , 1992, Journal of the Neurological Sciences.

[123]  E. Neafsey,et al.  Indole-N-methylated β-carbolinium ions as potential brain-bioactivated neurotoxins , 1992, Brain Research.

[124]  E. Parati,et al.  The chemical characterization of melanin contained in substantia nigra of human brain. , 1992, Biochimica et biophysica acta.

[125]  J. Connor,et al.  A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains , 1992, Journal of neuroscience research.

[126]  W. Koller.  Initiating treatment of Parkinson's disease , 1992, Neurology.

[127]  C. Agardh,et al.  Free radical production and ischemic brain damage: Influence of postischemic oxygen tension , 1991, International Journal of Developmental Neuroscience.

[128]  R. Tasker,et al.  Hippocampal damage produced by systemic injections of domoic acid in mice , 1991, Neuroscience.

[129]  L. Oreland,et al.  Monoamine oxidase B in brains from patients with Alzheimer's disease: A biochemical and autoradiographical study , 1991, Neuroscience.

[130]  R. Simone,et al.  Effect of acetyl-L-carnitine on forebrain cholinergic neurons of developing rats , 1991, International Journal of Developmental Neuroscience.

[131]  A. Foster,et al.  An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo , 1991, Neuroscience.

[132]  G. Moore,et al.  The Uptake, Storage, And Mobilization Of Iron And Aluminum In Biology , 1991 .

[133]  H. Przuntek,et al.  MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. , 1991, European journal of pharmacology.

[134]  C. Hoppel,et al.  Dopaminergic Neurotoxicity In Vivo and Inhibition of Mitochondrial Respiration In Vitro by Possible Endogenous Pyridinium‐Like Substances , 1991, Journal of neurochemistry.

[135]  W. Tatton,et al.  Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism , 1991, Journal of neuroscience research.

[136]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[137]  D. Ben-shachar,et al.  Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats , 1991, Journal of neurochemistry.

[138]  M. Piccirilli,et al.  L-deprenyl therapy improves verbal memory in amnesic Alzheimer patients. , 1991, Clinical neuropharmacology.

[139]  C. Masters,et al.  Mechanisms of Amyloid Deposition in Alzheimer's Disease a , 1991, Annals of the New York Academy of Sciences.

[140]  M. Smith,et al.  Neurocytotoxicity: pharmacological implications , 1991, Fundamental & clinical pharmacology.

[141]  J. Rabey,et al.  The influence of bromocriptine on the pharmacokinetics of levodopa in Parkinson's disease. , 1991, Clinical neuropharmacology.

[142]  T. Kawashima,et al.  α-Tocopherol supports the survival and neurite extension of neurons cultured from various regions of fetal rat brain , 1991, Neuroscience Letters.

[143]  D. Yin,et al.  Oxidized ascorbic acid and reaction products between ascorbic and amino acids might constitute part of age pigments , 1991, Mechanisms of Ageing and Development.

[144]  T. Klockgether,et al.  The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine‐depleted rats and MPTP‐treated monkeys , 1991, Annals of neurology.

[145]  C. Klein,et al.  The role of oxidative processes in metal carcinogenesis. , 1991, Chemical research in toxicology.

[146]  M. Alberoni,et al.  Long‐term acetyl‐L‐carnitine treatment in Alzheimer's disease , 1991, Neurology.

[147]  K. Jellinger,et al.  The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease , 1991, Journal of neuropathology and experimental neurology.

[148]  P. Riederer,et al.  Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease , 1991, Journal of neurochemistry.

[149]  A. Lajtha,et al.  Effect of acetyl‐L‐carnitine on the dopaminergic system in aging brain , 1991, Journal of neuroscience research.

[150]  K. Kasprzak.  The role of oxidative damage in metal carcinogenicity. , 1991, Chemical research in toxicology.

[151]  Masoro Ej.  Biology of aging: facts, thoughts, and experimental approaches. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[152]  J. Penney,et al.  2,4,5-Trihydroxyphenylalanine (6-hydroxy-DOPA) displaces [3H]AMPA binding in rat striatum , 1991, Neuroscience Letters.

[153]  W. Tatton,et al.  Transmitter synthesis increases in substantia nigra neurons of the aged mouse , 1991, Neuroscience Letters.

[154]  C. Lee,et al.  Initiation of lipid peroxidation in submitochondrial particles: effect of respiratory inhibitors. , 1991, Archives of biochemistry and biophysics.

[155]  R. S. Sohal.  Hydrogen peroxide production by mitochondria may be a biomarker of aging , 1991, Mechanisms of Ageing and Development.

[156]  M. Horwitt.  The term alpha-tocopherol should not be used without clarification. , 1991, The American journal of clinical nutrition.

[157]  T. Ozawa,et al.  Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease , 1991, Annals of neurology.

[158]  R. Lammintausta,et al.  A review of the pharmacology of selegiline , 1991, Acta neurologica Scandinavica. Supplementum.

[159]  H. Rommelspacher,et al.  β-Carbolines and Tetrahydroisoquinolines: Detection and Function in Mammals , 1991, Planta medica.

[160]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[161]  K. Wakamatsu,et al.  Cysteinyldopamine is not incorporated into neuromelanin , 1991, Neuroscience Letters.

[162]  E. Rosengren,et al.  The neuromelanin of the human substantia nigra. , 1991, Biochimica et biophysica acta.

[163]  E. Stadtman,et al.  Fenton chemistry. Amino acid oxidation. , 1991, The Journal of biological chemistry.

[164]  R. Kostrzewa,et al.  Vitamin E supplements fail to protect mice from acute MPTP neurotoxicity. , 1991, Neuroreport.

[165]  M. Simic,et al.  Dietary modulation of DNA damage in human. , 1991, Mutation research.

[166]  J. Joshi,et al.  Ferritin: The role of aluminum in ferritin function , 1991, Neurobiology of Aging.

[167]  K. Steimer,et al.  Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[168]  R. Mordi.  Exploratory study of -carotene autoxidation , 1991 .

[169]  V. Ravindranath,et al.  Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducer: in vitro studies with brain slices , 1991, Brain Research.

[170]  D. Turnbull,et al.  Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease , 1991, Journal of the Neurological Sciences.

[171]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.

[172]  O. Pastoris,et al.  Age‐related acute depletion of cerebral glutathione by peroxidative stress , 1991, Journal of neuroscience research.

[173]  P. Johannsen,et al.  Glutathione peroxidase in early and advanced Parkinson's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[174]  I. Tomita,et al.  Production of aliphatic aldehydes on peroxidation of various types of lipids. , 1991, Chemical & pharmaceutical bulletin.

[175]  A. Wilson,et al.  Paternal inheritance of mitochondrial DNA in mice , 1991, Nature.

[176]  Yau-Huei Wei,et al.  Ageing-associated 5 kb deletion in human liver mitochondrial DNA. , 1991, Biochemical and biophysical research communications.

[177]  G. Dallner,et al.  Inhibition of lipid peroxidation by ubiquinol in submitochondrial particles in the absence of vitamin E , 1991, FEBS letters.

[178]  F. Artigas,et al.  Changes in Polyamine Levels in Rat Brain After Systemic Kainic Acid Administration: Relationship to Convulsant Activity and Brain Damage , 1991, Journal of neurochemistry.

[179]  J. Montastruc.  Recent advances in the clinical pharmacology of Parkinson's disease. , 1991, Therapie.

[180]  A. Delacourte,et al.  Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome , 1991, Brain Research.

[181]  M. Calvani,et al.  Clues to the Mechanism of Action of Acetyl-L-Carnitine in the Central Nervous System , 1991 .

[182]  C. Miller,et al.  Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. , 1991, Molecular and chemical neuropathology.

[183]  Yves Agid,et al.  Parkinson's disease: pathophysiology , 1991, The Lancet.

[184]  A. Meister,et al.  Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[185]  H. Okamura,et al.  Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum , 1991, Brain Research.

[186]  J. Haines,et al.  Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. , 1991, The New England journal of medicine.

[187]  M. Scott,et al.  NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes. , 1991, Blood.

[188]  D. Liebler,et al.  Peroxyl radical oxidation of beta-carotene: formation of beta-carotene epoxides. , 1991, Chemical research in toxicology.

[189]  L. Horrocks,et al.  Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders , 1991, Brain Research Reviews.

[190]  J. Shih,et al.  Human monoamine oxidase A and B genes exhibit identical exon-intron organization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[191]  G. Zeevalk,et al.  Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. , 1991, The Journal of pharmacology and experimental therapeutics.

[192]  A. Carlsson,et al.  Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig , 1991, Neuropharmacology.

[193]  K. Jellinger,et al.  Mitochondrial DNA in Postmortem Brain from Patients with Parkinson's Disease , 1991, Journal of neurochemistry.

[194]  Y. Mizoi,et al.  Identification of tetrahydro-beta-carboline-3-carboxylic acid in foodstuffs, human urine and human milk. , 1991, The Journal of nutrition.

[195]  G. Siest,et al.  Drug metabolizing enzymes in the brain and cerebral microvessels , 1991, Brain Research Reviews.

[196]  C. Halldin,et al.  Quantitative localization of human brain monoamine oxidase B by large section autoradiography using l-[3H]deprenyl , 1991, Brain Research.

[197]  J. Bormann,et al.  Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study. , 1991, European journal of pharmacology.

[198]  G. Taglialatela,et al.  Acetyl-L-carnitine enhances the response of PC12 cells to nerve growth factor. , 1991, Brain research. Developmental brain research.

[199]  Barry Halliwell,et al.  DNA damage by oxygen‐derived species Its mechanism and measurement in mammalian systems , 1991, FEBS letters.

[200]  D. Ben-shachar,et al.  The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons , 1991, Journal of neurochemistry.

[201]  E. Southam,et al.  Experimental vitamin E deficiency in rats. Morphological and functional evidence of abnormal axonal transport secondary to free radical damage. , 1991, Brain : a journal of neurology.

[202]  J. Casida,et al.  Interaction of 1‐Methyl‐4‐Phenylpyridinium Ion (MPP+) and Its Analogs with the Rotenone/Piericidin Binding Site of NADH Dehydrogenase , 1991, Journal of neurochemistry.

[203]  A. Harding.  Neurological disease and mitochondrial genes , 1991, Trends in Neurosciences.

[204]  D. Selkoe.  The molecular pathology of Alzheimer's disease , 1991, Neuron.

[205]  G. Yancopoulos,et al.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra , 1991, Nature.

[206]  P. Werner,et al.  Intramitochondrial formation of oxidized glutathione during the oxidation of benzylamine by monoamine oxidase , 1991, FEBS letters.

[207]  P Riederer,et al.  Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.

[208]  H. Padh.  Vitamin C: newer insights into its biochemical functions. , 1991, Nutrition reviews.

[209]  J. Hauw,et al.  Absence of aluminium in Alzheimer's disease brain tissue: Electron microprobe and ion microprobe studie , 1991, Neuroscience Letters.

[210]  Y. Agid,et al.  Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis , 1991, Journal of neurochemistry.

[211]  R. S. Sohal,et al.  Hydrogen peroxide release by mitochondria increases during aging , 1991, Mechanisms of Ageing and Development.

[212]  J. Cadet,et al.  Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats , 1991, Brain Research Bulletin.

[213]  K. Reuhl,et al.  Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence. , 1991, Toxicology and applied pharmacology.

[214]  P. Cerutti,et al.  Oxidant stress and carcinogenesis , 1991, European journal of clinical investigation.

[215]  S. Hirai,et al.  Dopa and dopamine cause cultured neuronal death in the presence of iron , 1991, Journal of the Neurological Sciences.

[216]  A. Carlsson,et al.  Vitamin C Deficiency Facilitates 5‐S‐Cysteinyldopamine Formation in Guinea Pig Striatum , 1991, Journal of neurochemistry.

[217]  B. Bielski,et al.  Highlights of current research involving superoxide and perhydroxyl radicals in aqueous solutions. , 1991, International journal of radiation biology.

[218]  J. Cooper,et al.  Drug treatment of Alzheimer's disease. , 1991, Archives of internal medicine.

[219]  I. Kopin,et al.  2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam , 1991 .

[220]  M. Youdim,et al.  New directions in monoamine oxidase A and B selective inhibitors and substrates. , 1991, Biochemical pharmacology.

[221]  R. G. Allen,et al.  Oxidative stress as a causal factor in differentiation and aging: a unifying hypothesis , 1990, Experimental Gerontology.

[222]  R. Faull,et al.  Alzheimer's disease: Changes in hippocampal N-methyl-d-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors—an autoradiographic study , 1990, Neuroscience.

[223]  E. London,et al.  Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate , 1990, Brain Research.

[224]  J. Growdon,et al.  Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients , 1990, Brain Research.

[225]  R. Sutherland,et al.  Domoic acid, an environmental toxin, produces hippocampal damage and severe memory impairment , 1990, Neuroscience Letters.

[226]  C. Marsden,et al.  Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease , 1990, Journal of neurochemistry.

[227]  E. Neafsey,et al.  Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[228]  A. Boulton,et al.  2‐Phenylethylamine: A Modulator of Catecholamine Transmission in the Mammalian Central Nervous System? , 1990, Journal of neurochemistry.

[229]  M. Swash,et al.  Clinical features and associations of 560 cases of motor neuron disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[230]  A. Murakami,et al.  Cautionary note for DMPO spin trapping in the presence of iron ion. , 1990, Biochemical and biophysical research communications.

[231]  M. Collins,et al.  Brain and Plasma Tetrahydroisoquinolines in Rats: Effects of Chronic Ethanol Intake and Diet , 1990, Journal of neurochemistry.

[232]  K. Jellinger,et al.  Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect , 1990, Journal of neurochemistry.

[233]  T. Niwa,et al.  Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: The behavioral and biochemical changes , 1990, Neuroscience Letters.

[234]  K. Ohno,et al.  Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. , 1990, Biochemical and biophysical research communications.

[235]  G. Brewer,et al.  Gangliosides and synaptic transmission. , 1990, Biochimica et biophysica acta.

[236]  N. Mantel,et al.  Geographic patterns of parkinsonism-dementia complex on Guam. 1956 through 1985. , 1990, Archives of neurology.

[237]  C. Bergeron,et al.  Brain amino acid contents are dissimilar in sporadic and Guamanian amyotrophic lateral sclerosis , 1990, Journal of the Neurological Sciences.

[238]  M. Albert,et al.  GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice , 1990, Journal of the Neurological Sciences.

[239]  I. Romslo,et al.  The role of transferrin in the mechanism of cellular iron uptake. , 1990, The Biochemical journal.

[240]  Sara Romero,et al.  GM-1 treatment of Alzheimer's disease. A pilot study of safety and efficacy. , 1990, Archives of neurology.

[241]  F. Roisen,et al.  Gangliosides prevent MPTP toxicity in mice - an immunocytochemical study , 1990, Brain Research.

[242]  L. Ernster,et al.  Hydrogen peroxide production by monoamine oxidase in isolated rat-brain mitochondria: its effect on glutathione levels and Ca2+ efflux. , 1990, Biochimica et biophysica acta.

[243]  J. Garthwaite,et al.  Excitatory amino acid neurotoxicity and neurodegenerative disease. , 1990, Trends in pharmacological sciences.

[244]  K. Ohno,et al.  Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. , 1990, Biochemical and biophysical research communications.

[245]  J. Morris,et al.  Tyrosine hydroxylase-like (TH) immunoreactivity in human mesolimbic system , 1990, Neuroscience Letters.

[246]  C. Filley,et al.  Cytochrome oxidase deficiency in Alzheimer's disease , 1990, Neurology.

[247]  I. Módy,et al.  Differential activation of glutamate receptors by spontaneously released transmitter in slices of neocortex , 1990, Neuroscience Letters.

[248]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[249]  L. Ang,et al.  Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro , 1990, Journal of neurochemistry.

[250]  W Singer,et al.  Excitatory amino acid receptors and synaptic plasticity. , 1990, Trends in pharmacological sciences.

[251]  C. Marsden,et al.  Decreased Ferritin Levels in Brain in Parkinson's Disease , 1990, Journal of neurochemistry.

[252]  Marian DiFiglia,et al.  Excitotoxic injury of the neostriatum: a model for Huntington's disease , 1990, Trends in Neurosciences.

[253]  B. Halliwell,et al.  The antioxidants of human extracellular fluids. , 1990, Archives of biochemistry and biophysics.

[254]  A. Plaitakis.  Glutamate dysfunction and selective motor neuron degeneration inamyotrophic lateral sclerosis: A hypothesis , 1990, Annals of neurology.

[255]  L. Packer,et al.  Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. , 1990, Biochemical and biophysical research communications.

[256]  R. Zatorre,et al.  Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. , 1990, The New England journal of medicine.

[257]  T. Netscher,et al.  Chromatographische Trennung und quantitative Bestimmung aller acht Stereoisomeren von α‐Tocopherol , 1990 .

[258]  A. Hruszkewycz,et al.  The 8-hydroxyguanine content of isolated mitochondria increases with lipid peroxidation. , 1990, Mutation research.

[259]  T. Oltersdorf,et al.  Cleavage of amyloid beta peptide during constitutive processing of its precursor. , 1990, Science.

[260]  H. Esterbauer,et al.  Effect of 4-hydroxylalkenals on hepatic phosphatidylinositol-4,5-bisphosphate-phospholipase C. , 1990, Biochemical pharmacology.

[261]  J. Olney,et al.  Excitotoxicity of l-DOPA and 6-OH-DOPA: Implications for Parkinson's and Huntington's diseases , 1990, Experimental Neurology.

[262]  O. Pastoris,et al.  Influence of oxidative stress on the age‐linked alterations of the cerebral glutathione system , 1990, Journal of neuroscience research.

[263]  Sanford P. Markey,et al.  2‐Amino‐3‐(methylamino)‐propanoic acid (BMAA) in cycad flour , 1990, Neurology.

[264]  Y. Agid,et al.  Superoxide dismutase and Parkinson's disease , 1990, The Lancet.

[265]  D. Price,et al.  Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.

[266]  B. Halliwell,et al.  The measurement and mechanism of lipid peroxidation in biological systems. , 1990, Trends in biochemical sciences.

[267]  E. Hall,et al.  Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma. , 1990, Journal of medicinal chemistry.

[268]  A. Girotti,et al.  PHOTODYNAMIC LIPID PEROXIDATION IN BIOLOGICAL SYSTEMS * , 1990, Photochemistry and photobiology.

[269]  R. Lovelace,et al.  Motor neuron disease and amyotrophic lateral sclerosis , 1990, Neurology.

[270]  S. Shankar,et al.  NADPH cytochrome P-450 reductase in rat, mouse and human brain. , 1990, Biochemical pharmacology.

[271]  C. Gottfries.  Neurochemical Aspects of Dementia Disorders , 1990 .

[272]  G. Jackson,et al.  Role of nerve growth factor in oxidant‐antioxidant balance and neuronal injury. II. A conditioning lesion paradigm , 1990, Journal of neuroscience research.

[273]  C. Drevon,et al.  Absorption, transport and distribution of vitamin E. , 1990, The Journal of nutrition.

[274]  G. Jackson,et al.  Role of nerve growth factor in oxidant‐antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance , 1990, Journal of neuroscience research.

[275]  Douglas C. Miller,et al.  A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.

[276]  G. Fagg,et al.  Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. , 1990, Trends in pharmacological sciences.

[277]  J. Goldsmith,et al.  Clustering of Parkinson's disease points to environmental etiology. , 1990, Archives of environmental health.

[278]  C. Marsden,et al.  Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.

[279]  R. M. Miller,et al.  Phosphorylase and creatine kinase modification by thiol-disulfide exchange and by xanthine oxidase-initiated S-thiolation. , 1990, Archives of biochemistry and biophysics.

[280]  J. C. Stoof,et al.  The quinolinic acid hypothesis in Huntington's chorea , 1990, Journal of the Neurological Sciences.

[281]  L. Klaidman,et al.  MPTP toxicity in the mouse brain and vitamin E , 1990, Neuroscience Letters.

[282]  A. Girotti,et al.  Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. , 1990, The Journal of biological chemistry.

[283]  H. Heinsen,et al.  Demonstration of monoamine oxidase-A and -B in the human brainstem by a histochemical technique , 1989, Neuroscience.

[284]  M. Naoi,et al.  N-methylisoquinolinium ion as an inhibitor of tyrosine hydroxylase, aromatic l-amino acid decarboxylase and monoamine oxidase , 1989, Neurochemistry International.

[285]  E. Melloni,et al.  The calpains , 1989, Trends in Neurosciences.

[286]  C. Tanner,et al.  The role of environmental toxins in the etiology of Parkinson's disease , 1989, Trends in Neurosciences.

[287]  Y. Wei,et al.  Liver mitochondrial respiratory functions decline with age. , 1989, Biochemical and biophysical research communications.

[288]  A. Imperato,et al.  Acetyl-l-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats , 1989, Neuroscience Letters.

[289]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[290]  R. Nicoll,et al.  Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. , 1989, Science.

[291]  G. Cohen,et al.  Deprenyl suppresses the oxidant stress associated with increased dopamine turnover , 1989, Annals of neurology.

[292]  B. Halliwell.  Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? , 1989, Acta neurologica Scandinavica. Supplementum.

[293]  W. Jagust,et al.  Regional cerebral glucose transport and utilization in Alzheimer's disease , 1989, Neurology.

[294]  P. Riederer,et al.  Neurochemical perspectives to the function of monoamine oxidase , 1989, Acta neurologica Scandinavica. Supplementum.

[295]  A. Eisen,et al.  The Relationship Between Alzheimer's Disease, Parkinson's Disease and Motor Neuron Disease , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[296]  R N Kalaria,et al.  Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease , 1989, Journal of neurochemistry.

[297]  Y. Agid,et al.  Striatal dopamine deficiency in parkinson's disease: Role of aging , 1989, Annals of neurology.

[298]  S. Ho,et al.  Epidemiologic study of Parkinson's disease in Hong Kong , 1989, Neurology.

[299]  R. Rose.  The Ascorbate Redox Potential of Tissues: A Determinant or Indicator of Disease? , 1989 .

[300]  D. Nelson,et al.  Evolution of the cytochrome P450 genes. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[301]  Y. Kagawa,et al.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. , 1989, Biochemical and biophysical research communications.

[302]  J. Growdon,et al.  Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease , 1989, Annals of neurology.

[303]  L. Karam,et al.  Generation of oxy radicals in biosystems. , 1989, Mutation research.

[304]  C. Marsden,et al.  A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra , 1989, Journal of neurochemistry.

[305]  D. Roy,et al.  β‐N‐Oxalylamino‐L‐Alanine Action on Glutamate Receptors , 1989, Journal of neurochemistry.

[306]  R. Uitti,et al.  Regional Metal Concentrations in Parkinson's Disease, Other Chronic Neurological Diseases, and Control Brains , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[307]  V. Ravindranath,et al.  High activity of cytochrome P-450-linked aminopyrine N-demethylase in mouse brain microsomes, and associated sex-related difference. , 1989, The Biochemical journal.

[308]  J. Lai,et al.  Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons , 1989, Brain Research.

[309]  A. Boobis,et al.  Mechanisms of cell death. , 1989, Trends in pharmacological sciences.

[310]  S. Orrenius,et al.  Role of Ca2+ in toxic cell killing. , 1989, Trends in pharmacological sciences.

[311]  M. Naoi,et al.  A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion. , 1989, Biochemical and biophysical research communications.

[312]  A. H. V. Schapira,et al.  MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.

[313]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[314]  W. Gibb.  Neuropathology in movement disorders. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[315]  P. Sonsalla,et al.  Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. , 1989, Molecular and chemical neuropathology.

[316]  G. Reynolds,et al.  Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata , 1989, Neuroscience Letters.

[317]  C. Bergeron,et al.  The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease , 1989, Neuroscience Letters.

[318]  M. Beal,et al.  Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseases , 1989, Brain Research.

[319]  G. Ebers,et al.  Abnormalities in Iron Metabolism in Multiple Sclerosis , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[320]  S. Orrenius,et al.  Cytoskeletal alterations in human platelets exposed to oxidative stress are mediated by oxidative and Ca2+-dependent mechanisms. , 1989, Archives of biochemistry and biophysics.

[321]  A. Mariani,et al.  GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study , 1989, Brain Research.

[322]  D. Calne,et al.  Clozapine: an antipsychotic agent in Parkinson's disease? , 1989, Clinical neuropharmacology.

[323]  B. Siesjö,et al.  Calcium Fluxes, Calcium Antagonists, and Calcium-Related Pathology in Brain Ischemia, Hypoglycemia, and Spreading Depression: A Unifying Hypothesis , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[324]  T. Ludden,et al.  Exhaled alkanes as indices of in vivo lipid peroxidation. , 1989, Biochemical pharmacology.

[325]  Edward Byrne,et al.  DECLINE IN SKELETAL MUSCLE MITOCHONDRIAL RESPIRATORY CHAIN FUNCTION: POSSIBLE FACTOR IN AGEING , 1989, The Lancet.

[326]  R. Kido,et al.  Enhancement by catechols of hydroxyl-radical formation in the presence of ferric ions and hydrogen peroxide. , 1989, Journal of biochemistry.

[327]  E. Pileblad,et al.  Reduction of Brain Glutathione by l‐Buthionine Sulfoximine Potentiates the Dopamine‐Depleting Action of 6‐Hydroxydopamine in Rat Striatum , 1989, Journal of neurochemistry.

[328]  M. Strolin Benedetti,et al.  Monoamine oxidase, brain ageing and degenerative diseases. , 1989, Biochemical pharmacology.

[329]  C. Marsden,et al.  Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.

[330]  M. Naoi,et al.  Oxidation of N‐Methyl‐1,2,3,4‐Tetrahydroisoquinoline into the N‐Methyl‐Isoquinolinium Ion by Monoamine Oxidase , 1989, Journal of neurochemistry.

[331]  Peter Riederer,et al.  Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.

[332]  G. Cohen,et al.  Dopamine turnover and glutathione oxidation: implications for Parkinson disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[333]  J. Whitsett,et al.  Synthesis and processing of the precursor for human mangano-superoxide dismutase. , 1989, Biochimica et biophysica acta.

[334]  L. Oreland,et al.  The cholinergic neurotoxin ethylcholine mustard aziridinium (AF64A) induces an increase in MAO-B activity in the rat brain , 1989, Brain Research.

[335]  M. Hecker,et al.  On the mechanism of prostacyclin and thromboxane A2 biosynthesis. , 1989, The Journal of biological chemistry.

[336]  F. Zemlan,et al.  Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation , 1989, Brain Research.

[337]  J. Cadet,et al.  Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: Behavioral and biochemical evidence , 1989, Brain Research.

[338]  David F Wilson,et al.  Lipid Hydroperoxides Inhibit Reacylation of Phospholipids in Neuronal Membranes , 1989, Journal of neurochemistry.

[339]  M. Blaustein.  Calcium transport and buffering in neurons , 1988, Trends in Neurosciences.

[340]  J. Knoll.  The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenyl , 1988, Mechanisms of Ageing and Development.

[341]  D. Choi.  Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage , 1988, Trends in Neurosciences.

[342]  L. Kurland,et al.  Amyotrophic lateral sclerosis and parkinson's disease complex on Guam linked to an environmental neurotoxin , 1988, Trends in Neurosciences.

[343]  F. Moroni,et al.  INCREASED KYNURENIC ACID LEVELS IN HUNTINGTON'S DISEASE , 1988, The Lancet.

[344]  Arlen W. Johnson,et al.  Yeast DNA 3'-repair diesterase is the major cellular apurinic/apyrimidinic endonuclease: substrate specificity and kinetics. , 1988, The Journal of biological chemistry.

[345]  C. Richter.  Do mitochondrial DNA fragments promote cancer and aging? , 1988, FEBS letters.

[346]  L. Golbe,et al.  Case-control study of early life dietary factors in Parkinson's disease. , 1988, Archives of neurology.

[347]  Haruhiko Akiyama,et al.  Rate of cell death in parkinsonism indicates active neuropathological process , 1988, Annals of neurology.

[348]  D. Choi,et al.  Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.

[349]  D. Muller,et al.  Longitudinal studies of the neurobiology of vitamin E and other antioxidant systems, and neurological function in the vitamin E deficient rat , 1988, Journal of Neurological Sciences.

[350]  J. Pettegrew,et al.  Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease. , 1988, Archives of neurology.

[351]  B. Halliwell,et al.  Action of lead(II) and aluminium (III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions. , 1988, Biochimica et biophysica acta.

[352]  W. Smith,et al.  Cellular response to oxidative stress at sulfhydryl group receptor sites on the erythrocyte membrane. , 1988, The Journal of biological chemistry.

[353]  B. Ames,et al.  Normal oxidative damage to mitochondrial and nuclear DNA is extensive. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[354]  R. Marttila,et al.  Oxygen toxicity protecting enzymes in Parkinson's disease Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus , 1988, Journal of the Neurological Sciences.

[355]  D. Sparks,et al.  Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus. , 1988, Archives of neurology.

[356]  A. Plaitakis,et al.  The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis , 1988, Annals of neurology.

[357]  K. Jellinger,et al.  Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stem , 1988, Neuroscience.

[358]  J. Cadet,et al.  The repairability of oxidative free radical mediated damage to DNA: a review. , 1988, International journal of radiation biology.

[359]  A. Graybiel,et al.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.

[360]  P. Seeburg,et al.  cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[361]  P. Wood.  The potential diagram for oxygen at pH 7. , 1988, The Biochemical journal.

[362]  A. Novelli,et al.  Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced , 1988, Brain Research.

[363]  H. Sies,et al.  The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. , 1988, European journal of biochemistry.

[364]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[365]  G. Reynolds,et al.  Brain Quinolinic Acid in Huntington's Disease , 1988, Journal of neurochemistry.

[366]  R. M. Rose,et al.  Localization of distinct monoamine oxidase a and monoamine oxidase b cell populations in human brainstem , 1988, Neuroscience.

[367]  T. Nagatsu,et al.  An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions , 1988, Neuroscience Letters.

[368]  B. Ames,et al.  Oxidative damage to DNA: relation to species metabolic rate and life span. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[369]  J. Gustafsson,et al.  Regional Distribution of Cytochrome P‐450 in the Rat Brain: Spectral Quantitation and Contribution of P‐450b,e and P‐450c,d , 1988, Journal of neurochemistry.

[370]  R. Capaldi,et al.  Mitochondrial myopathies and respiratory chain proteins. , 1988, Trends in biochemical sciences.

[371]  Y. Mizuno,et al.  Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity and ATP synthesis by tetrahydroisoquinoline , 1988, Neuroscience Letters.

[372]  L. Horrocks,et al.  Stimulation of lipolytic enzymes in alzheimer's disease , 1988, Annals of neurology.

[373]  M. Ozaki,et al.  Iron release from haemosiderin and production of iron-catalysed hydroxyl radicals in vitro. , 1988, The Biochemical journal.

[374]  M. Nishikimi,et al.  Deficiency of subunits of complex I and mitochondrial encephalomyopathy , 1988, Annals of neurology.

[375]  J. Ulrich,et al.  Effects of aluminium chloride on cultured cells from rat brain hemispheres , 1988, Brain Research.

[376]  E. D. Harris,et al.  Regulation of aortic CuZn-superoxide dismutase with copper. Effects in vivo. , 1987, The Biochemical journal.

[377]  E. D. Harris,et al.  Regulation of aortic CuZn-superoxide dismutase with copper. Caeruloplasmin and albumin re-activate and transfer copper to the enzyme in culture. , 1987, The Biochemical journal.

[378]  D. Neary,et al.  Mitochondrial function in brain tissue in primary degenerative dementia , 1987, Brain Research.

[379]  C. Sonntag,et al.  The chemical basis of radiation biology , 1987 .

[380]  N. Shaklai,et al.  Glutathione as a scavenger of free hemin. A mechanism of preventing red cell membrane damage. , 1987, Biochemical pharmacology.

[381]  J. Joshi,et al.  Ferritin: isolation of aluminum-ferritin complex from brain. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[382]  James M. Wright,et al.  α-Tocopherol and β-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 1987, Journal of the Neurological Sciences.

[383]  A. Stern,et al.  Mechanism of Kainate Toxicity to Cerebellar Neurons In Vitro Is Analogous to Reperfusion Tissue Injury , 1987, Journal of neurochemistry.

[384]  L. Oreland,et al.  Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species. , 1987, Biochemical pharmacology.

[385]  P. Larsen,et al.  MELAS syndrome involving a mother and two children. , 1987, Archives of neurology.

[386]  J. Poirier,et al.  DEBRISOQUINE METABOLISM IN PARKINSONIAN PATIENTS TREATED WITH ANTIHISTAMINE DRUGS , 1987, The Lancet.

[387]  J. Mccall,et al.  Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. , 1987, The Journal of biological chemistry.

[388]  R. Uitti,et al.  Geography, Drinking Water Chemistry, Pesticides and Herbicides and the Etiology of Parkinson's Disease , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[389]  D L Price,et al.  Aminergic systems in Alzheimer's disease and Parkinson's disease , 1987, Annals of neurology.

[390]  E. Niki,et al.  Antioxidants in relation to lipid peroxidation. , 1987, Chemistry and physics of lipids.

[391]  E. Niki.  Interaction of Ascorbate and α‐Tocopherol , 1987 .

[392]  A. Goldberg,et al.  Proteins damaged by oxygen radicals are rapidly degraded in extracts of red blood cells. , 1987, The Journal of biological chemistry.

[393]  D. Price,et al.  Reductions in corticotropin releasing factor‐like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy , 1987, Neurology.

[394]  E. Perry,et al.  Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[395]  A. Slivka,et al.  Histochemical evaluation of glutathione in brain , 1987, Brain Research.

[396]  J. Hawthorne,et al.  Reduced Phosphoinositide Concentrations in Anterior Temporal Cortex of Alzheimer‐Diseased Brains , 1987, Journal of neurochemistry.

[397]  D. D. Di Monte,et al.  Studies on the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytotoxicity in isolated hepatocytes. , 1987, Life sciences.

[398]  A. Slivka,et al.  Reduced and oxidized glutathione in human and monkey brain , 1987, Neuroscience Letters.

[399]  M. Esiri,et al.  Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease , 1987, Brain Research.

[400]  R. Cunningham,et al.  A highly conserved endonuclease activity present in Escherichia coli, bovine, and human cells recognizes oxidative DNA damage at sites of pyrimidines , 1987, Molecular and cellular biology.

[401]  L. Kochersperger,et al.  Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[402]  E. Niki,et al.  Oxidation of a Vitamin E Model Compound, 2,2,5,7,8-Pentamethylchroman-6-ol, with the tert-Butylperoxyl Radical. , 1986 .

[403]  H. Sies.  Biochemie des oxidativen Stress , 1986 .

[404]  P. Wood,et al.  Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease , 1986, Neuroscience.

[405]  K. Yamamoto,et al.  The biological activity of hydrogen peroxide. IV. Enhancement of its clastogenic actions by coadministration of L-histidine. , 1986 .

[406]  A. Eisen,et al.  ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT? , 1986, The Lancet.

[407]  F. Buonanno,et al.  In Vitro31P NMR Spectroscopy Detects Altered Phospholipid Metabolism in Alzheimer's Disease , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[408]  W. Poewe,et al.  Low‐dose L‐dopa therapy in Parkinson's disease , 1986, Neurology.

[409]  A. Ootsuyama,et al.  Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. , 1986, Carcinogenesis.

[410]  T. Maeda,et al.  Topographic atlas of monoamine oxidase-containing neurons in the rat brain studied by an improved histochemical method , 1986, Neuroscience.

[411]  S. Gauthier,et al.  Neurotransmitter and Receptor Deficits in Senile Dementia of the Alzheimer Type , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[412]  W. Weiner,et al.  Nerve growth factor and Alzheimer's disease , 1986, Annals of neurology.

[413]  R. J. Stephens,et al.  Occurrence of 4-hydroxyalkenals in rat tissues determined as pentafluorobenzyl oxime derivatives by gas chromatography-mass spectrometry. , 1986, Biochemical and biophysical research communications.

[414]  E. Melamed,et al.  Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) , 1986, Neuroscience Letters.

[415]  S. Nishimura,et al.  Hydroxylation of guanine in nucleosides and DNA at the C-8 position by heated glucose and oxygen radical-forming agents. , 1986, Environmental health perspectives.

[416]  H. Nohl,et al.  The mitochondrial site of superoxide formation. , 1986, Biochemical and biophysical research communications.

[417]  S. Hunt,et al.  Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. , 1986, Brain research.

[418]  Voon Wee Yong,et al.  Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients , 1986, Neuroscience Letters.

[419]  G. Burton,et al.  Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function , 1986 .

[420]  I. Fridovich.  Biological effects of the superoxide radical. , 1986, Archives of biochemistry and biophysics.

[421]  N. Lenn,et al.  Migraine with tardy pleocytosis , 1986, Neurology.

[422]  D. Selkoe,et al.  INVESTIGATION OF SILICON AND ALUMINUM CONTENT IN ISOLATED SENILE PLAQUE CORES BY LASER MICROPROBE MASS ANALYSIS (LAMMA) , 1986 .

[423]  W. Haseltine,et al.  Mechanism of action of a mammalian DNA repair endonuclease. , 1986, Biochemistry.

[424]  R. Ramsay,et al.  Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism. , 1986, Biochemical and biophysical research communications.

[425]  S. Markey,et al.  1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent. , 1986, Life sciences.

[426]  E. Perry,et al.  ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE , 1986, The Lancet.

[427]  J. Olney,et al.  Glutamate and the pathophysiology of hypoxic–ischemic brain damage , 1986, Annals of neurology.

[428]  C. Markham,et al.  Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Behavior, histology, and biochemistry , 1986, Experimental Neurology.

[429]  R. Ramsay,et al.  Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+. , 1986, Biochemical and biophysical research communications.

[430]  V. Yong,et al.  Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment , 1986, Neuroscience Letters.

[431]  M. Rossor,et al.  Transmitter deficits in Alzheimer's disease , 1985, Neurochemistry International.

[432]  C. Gottfries.  Transmitter deficits in Alzheimer's disease , 1985, Neurochemistry International.

[433]  R. Carelli,et al.  Ascorbic acid reduces the dopamine depletion induced by MPTP , 1985, Neuropharmacology.

[434]  A. Lajtha,et al.  Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid , 1985, Neuropharmacology.

[435]  J. van der Zee,et al.  Site-specific and bulk-phase generation of hydroxyl radicals in the presence of cupric ions and thiol compounds. , 1985, The Biochemical journal.

[436]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[437]  A. Rivett,et al.  Purification of a liver alkaline protease which degrades oxidatively modified glutamine synthetase. Characterization as a high molecular weight cysteine proteinase. , 1985, The Journal of biological chemistry.

[438]  R. M. Rose,et al.  Distinct monoamine oxidase A and B populations in primate brain. , 1985, Science.

[439]  A. Ross,et al.  Reactivity of HO2/O−2 Radicals in Aqueous Solution , 1985 .

[440]  W. Bradley,et al.  Amyotrophic leteral sclerosis: Part 2. Etiopathogenesis , 1985 .

[441]  R. Clavier,et al.  Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse , 1985, Neuroscience Letters.

[442]  S. Kish,et al.  Glutathione peroxidase activity in Parkinson's disease brain , 1985, Neuroscience Letters.

[443]  I. Fridovich,et al.  Inactivation of glutathione peroxidase by superoxide radical. , 1985, Archives of biochemistry and biophysics.

[444]  J. C. Masdeu.  Locked‐in state induced by internal capsule or globus pallidus lesions? , 1985, Neurology.

[445]  B. Halliwell,et al.  Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts. , 1985, Biochimica et biophysica acta.

[446]  K. Ingold,et al.  Antioxidant and co-antioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. , 1985, Biochimica et biophysica acta.

[447]  Iain M McIntyre,et al.  Carbidopa effect on rat brain monoamine oxidase and pineal melatonin , 1985, Biological Psychiatry.

[448]  E. Niki,et al.  Oxidation of lipids. VIII. Synergistic inhibition of oxidation of phosphatidylcholine liposome in aqueous dispersion by vitamin E and vitamin C. , 1985 .

[449]  W. Nicklas,et al.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.

[450]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[451]  K. Chiba,et al.  Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. , 1985, Biochemical and biophysical research communications.

[452]  L. Pearce,et al.  Cellular localization of MAO A and B in brain: Evidence from kainic acid lesions in striatum , 1985, Brain Research.

[453]  S. Snyder,et al.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[454]  M. Bárány,et al.  INCREASED GLYCEROL-3-PHOSPHORYLCHOUNE IN POST-MORTEM ALZHEIMER'S BRAIN , 1985, The Lancet.

[455]  E. Rosengren,et al.  Production of 6-hydroxydopa by human tyrosinase. , 1985, Acta dermato-venereologica.

[456]  R. Wittes.  Vitamin C and cancer. , 1985, The New England journal of medicine.

[457]  T. Florence.  The production of hydroxyl radical from hydrogen peroxide , 1984 .

[458]  A. Bast,et al.  Cytochrome P-450 and glutathione: what is the significance of their interrelationship in lipid peroxidation? , 1984 .

[459]  Y. Agid,et al.  Adrenergic receptors in Parkinson's disease , 1984, Brain Research.

[460]  B. Meldrum,et al.  Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. , 1984, Science.

[461]  R. Duvoisin,et al.  Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors , 1984, Nature.

[462]  J. Langston,et al.  Pargyline prevents MPTP-induced parkinsonism in primates. , 1984, Science.

[463]  F. Ursini,et al.  Formation of α-tocopherol radical and recycling of α-tocopherol by ascorbate during peroxidation of phosphatidylcholine liposomes: An electron paramagnetic resonance study , 1984 .

[464]  B. Ames,et al.  Thymine glycol and thymidine glycol in human and rat urine: a possible assay for oxidative DNA damage. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[465]  C. Marsden,et al.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset , 1984, Neuroscience Letters.

[466]  A. Bendich,et al.  Interaction of dietary vitamin C and vitamin E on guinea pig immune responses to mitogens. , 1984, The Journal of nutrition.

[467]  A. Rajput,et al.  Chronic low‐dose levodopa therapy in Parkinson's disease , 1984, Neurology.

[468]  C. Knox,et al.  Effect of Age on Vitamin E Concentrations in Various Regions of the Brain and a Few Selected Peripheral Tissues of the Rat, and on the Uptake of Radioactive Vitamin E by Various Regions of Rat Brain , 1984, Journal of neurochemistry.

[469]  E. B. Paniago,et al.  Kinetic and mechanism of vesicle lipoperoxide decomposition by Fe(II) , 1984 .

[470]  S. Rothman.  Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[471]  R. Duvoisin,et al.  Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. , 1984, Science.

[472]  M. J. Coon,et al.  On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. Products of oxygen reduction. , 1984, The Journal of biological chemistry.

[473]  P. Mcgeer,et al.  Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain , 1984, Neurology.

[474]  C. Chow,et al.  Influence of dietary vitamin E and selenium on metabolic activation of chemicals to mutagens , 1984 .

[475]  B. Halliwell,et al.  Oxygen toxicity, oxygen radicals, transition metals and disease. , 1984, The Biochemical journal.

[476]  D. Mann,et al.  Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment , 1984, Mechanisms of Ageing and Development.

[477]  L. Rowland.  Motor neuron diseases and amyotrophic lateral sclerosis , 1984, Trends in Neurosciences.

[478]  C. Knox,et al.  Concentrations of vitamin E in various neuroanatomical regions and subcellular fractions, and the uptake of vitamin E by specific areas, of rat brain. , 1984, Biochimica et biophysica acta.

[479]  C. Rebert,et al.  Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey , 1984, Brain Research.

[480]  P. Yates,et al.  A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[481]  X. Lataste.  The History and Pharmacology of Dopamine Agonists , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[482]  J. Gustafsson,et al.  Presence of NADPH-cytochrome P450 reductase in central catecholaminergic neurones , 1984, Nature.

[483]  E. Shinar,et al.  The analogous mechanisms of enzymatic inactivation induced by ascorbate and superoxide in the presence of copper. , 1983, The Journal of biological chemistry.

[484]  E. Kosower,et al.  Membrane-mobility agent-promoted fusion of erythrocytes: fusibility is correlated with attack by calcium-activated cytoplasmic proteases on membrane proteins. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[485]  G. Czapski,et al.  On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism. , 1983, European journal of biochemistry.

[486]  Y. Agid,et al.  Somatostatin and dementia in Parkinson's disease , 1983, Brain Research.

[487]  L. Hager,et al.  Chloroperoxidase generation of singlet Δ molecular oxygen observed directly by spectroscopy in the 1- to 1.6-μm region , 1983 .

[488]  D. Ziegler,et al.  The enzymes of detoxication. , 1983, The Journal of biological chemistry.

[489]  L. Oreland,et al.  The effect of deprenyl (selegiline) on intra‐and extraneuronal dopamine oxidation , 1983, Acta neurologica Scandinavica. Supplementum.

[490]  K. Jellinger,et al.  Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline) , 1983, Acta neurologica Scandinavica. Supplementum.

[491]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[492]  B. Bielski,et al.  Kinetics and mechanism for the oxidation of ascorbic acid/ascorbate by HO2/O2- (hydroperoxyl/superoxide) radicals. A pulse radiolysis and stopped-flow photolysis study , 1983 .

[493]  D L Price,et al.  Basal forebrain neurons in the dementia of Parkinson disease , 1983, Annals of neurology.

[494]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[495]  David M. A. Mann,et al.  Possible role of neuromelanin in the pathogenesis of Parkinson's disease , 1983, Mechanisms of Ageing and Development.

[496]  P. Harrison,et al.  Effect of ferritin-containing fractions with different iron loading on lipid peroxidation. , 1983, The Biochemical journal.

[497]  M. Schmidt,et al.  The distribution and role of carnitine in the mammalian brain. , 1982, Life sciences.

[498]  A. Zhukov,et al.  Complete stoichiometry of free NADPH oxidation in liver microsomes. , 1982, Biochemical and biophysical research communications.

[499]  B. Babior.  The enzymatic basis for production by human neutrophils , 1982 .

[500]  H. Hayashi,et al.  Enzymatic analysis of individual anterior horn cells in amyotrophic lateral sclerosis and Duchenne muscular dystrophy , 1982, Journal of the Neurological Sciences.

[501]  B. Patten,et al.  Free amino acid concentrations in spinal tissue from patients dying of motor neuron disease , 1982, Acta neurologica Scandinavica.

[502]  H. Gilbert.  Biological disulfides: the third messenger? Modulation of phosphofructokinase activity by thiol/disulfide exchange. , 1982, The Journal of biological chemistry.

[503]  X. Breakefield,et al.  Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[504]  D. Price,et al.  Neurofibrillary axonal pathology in aluminum intoxication , 1982, Annals of neurology.

[505]  E. Kaplan,et al.  Cognitive fluctuations associated with on‐off phenomenon in Parkinson disease , 1982, Neurology.

[506]  C. C. Reddy,et al.  Vitamin E dependent reduced glutathione inhibition of rat liver microsomal lipid peroxidation. , 1982, Life sciences.

[507]  E. Diliberto,et al.  Tissue, Subcellular, and Submitochondrial Distributions of Semidehydroascorbate Reductase: Possible Role of Semidehydroascorbate Reductase in Cofactor Regeneration , 1982, Journal of neurochemistry.

[508]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[509]  M. Rockstein.  Handbook of Physiology in Aging , 1982 .

[510]  I. Fridovich,et al.  Superoxide radical inhibits catalase. , 1982, The Journal of biological chemistry.

[511]  C. Marsden.  The mysterious motor function of the basal ganglia , 1982, Neurology.

[512]  A. P. Autor.  Biosynthesis of mitochondrial manganese superoxide dismutase in saccharomyces cerevisiae. Precursor form of mitochondrial superoxide dismutase made in the cytoplasm. , 1982, The Journal of biological chemistry.

[513]  F. Ursini,et al.  Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. , 1982, Biochimica et biophysica acta.

[514]  B. Halliwell,et al.  Superoxide‐dependent formation of hydroxyl radicals in the presence of thiol compounds , 1982, FEBS letters.

[515]  J. Mortimer,et al.  Relationship of motor symptoms to intellectual deficits in Parkinson disease , 1982, Neurology.

[516]  Y. Agid,et al.  Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia , 1982, Brain Research.

[517]  S H Appel,et al.  A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease , 1981, Annals of neurology.

[518]  W. D. Ehmann,et al.  Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging , 1981, Annals of neurology.

[519]  Stefan L. Marklund,et al.  CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. , 1981, The Biochemical journal.

[520]  C. Neukom,et al.  TOTAL SYNTHESIS OF ALL EIGHT STEREOISOMERS OF α-TOCOPHERYL ACETATE. DETERMINATION OF THEIR DIASTEREOISOMERIC AND ENANTIOMERIC PURITY BY GAS CHROMATOGRAPHY , 1981 .

[521]  K. Ingold,et al.  Autoxidation of biological molecules. 1. Antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro , 1981 .

[522]  R. Wurtman,et al.  Long‐term administration of L‐DOPA does not damage dopaminergic neurons in the mouse , 1981, Neurology.

[523]  J. McCord,et al.  Superoxide radicals in feline intestinal ischemia. , 1981, Gastroenterology.

[524]  A. Hudson.  Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. , 1981, Brain : a journal of neurology.

[525]  B. Arrick,et al.  Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis , 1981, The Journal of experimental medicine.

[526]  V. Doležal,et al.  Utilization of Citrate, Acetylcarnitine, Acetate, Pyruvate and Glucose for the Synthesis of Acetylcholine in Rat Brain Slices , 1981, Journal of neurochemistry.

[527]  R. Terry,et al.  Fibrous Astrocytes in Senile Dementia of the Alzheimer Type , 1981, Journal of neuropathology and experimental neurology.

[528]  G. Cohen,et al.  Coupling of Dopamine Oxidation (Monoamine Oxidase Activity) to Glutathione Oxidation Via the Generation of Hydrogen Peroxide in Rat Brain Homogenates , 1981, Journal of neurochemistry.

[529]  H. Maker,et al.  Regional Distribution of Catalase in the Adult Rat Brain , 1981, Journal of neurochemistry.

[530]  M. Rossor,et al.  Mental symptoms in Huntington's disease and a possible primary aminergic neuron lesion. , 1980, Science.

[531]  H. Maker,et al.  Regional distribution of glutathione reductase in the adult rat brain , 1980, Brain Research.

[532]  Arthur J. L. Cooper,et al.  Glutathione and Ascorbate During Ischemia and Postischemic Reperfusion in Rat Brain , 1980, Journal of neurochemistry.

[533]  H. Wiśniewski,et al.  Aluminum chloride induced neurofibrillary changes in the developing rabbit: A chronic animal model , 1980, Annals of neurology.

[534]  J. Turrens,et al.  Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. , 1980, The Biochemical journal.

[535]  G. Cohen,et al.  Regional Distribution of Glutathione Peroxidase in the Adult Rat Brain , 1980, Journal of neurochemistry.

[536]  B. Winblad,et al.  Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. , 1980, Life sciences.

[537]  D. J. Reed,et al.  High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. , 1980, Analytical biochemistry.

[538]  P. Yates,et al.  Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia , 1980, British Journal of Psychiatry.

[539]  D. Perl,et al.  Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. , 1980, Science.

[540]  S. Rehncrona,et al.  Influence of Complete and Pronounced Incomplete Cerebral Ischemia and Subsequent Recirculation on Cortical Concentrations of Oxidized and Reduced Glutathione in the Rat , 1980, Journal of neurochemistry.

[541]  A. Carlsson,et al.  Monoamine oxidase -A and -B activity in the rat brain after hemitransection. , 1980, Life sciences.

[542]  W. Bors,et al.  Superoxide anions do not react with hydroperoxides , 1979, FEBS letters.

[543]  B. Winblad,et al.  Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type , 1979, British Journal of Psychiatry.

[544]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[545]  K. Iqbal,et al.  Brain aluminum in aging and Alzheimer disease , 1979, Neurology.

[546]  J. Packer,et al.  Direct observation of a free radical interaction between vitamin E and vitamin C , 1979, Nature.

[547]  J. Ordy,et al.  Age pigments, cell loss and hippocampal function , 1979, Mechanisms of Ageing and Development.

[548]  G. Reynolds,et al.  Deprenyl is metabolized to methamphetamine and amphetamine in man. , 1978, British journal of clinical pharmacology.

[549]  E K Perry,et al.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.

[550]  L. Sokoloff,et al.  Local cerebral glucose utilization in the normal conscious macaque monkey , 1978, Annals of neurology.

[551]  A. Rosen.  Amyotrophic lateral sclerosis. Clinical features and prognosis. , 1978, Archives of neurology.

[552]  J. Weisz,et al.  Direct inhibition of tyrosine hydroxylase activity by catechol estrogens. , 1978, The Journal of biological chemistry.

[553]  D. Graham,et al.  Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. , 1978, Molecular pharmacology.

[554]  P. Yates,et al.  The relationship between lipofuscin pigment and ageing in the human nervous system , 1978, Journal of the Neurological Sciences.

[555]  U. Roessmann,et al.  Kearns‐Sayre Syndrome with hypoparathyroidism , 1978, Annals of neurology.

[556]  R. Katzman.,et al.  NEURONAL PIGMENTS: SPECTROSCOPIC CHARACTERIZATION OF HUMAN BRAIN MELANIN , 1978, Journal of neurochemistry.

[557]  S. Paul,et al.  Catechol estrogen-forming enzyme of brain: demonstration of a cytochrome p450 monooxygenase. , 1977, Endocrinology.

[558]  M. Ames,et al.  Cytochrome P-450 and NADPH cytochrome c reductase in rat brain: formation of catechols and reactive catechol metabolites. , 1977, Biochemical and biophysical research communications.

[559]  A. Finazzi-Agro’,et al.  An attempt to evaluate the rate of the haber‐weiss reaction by using ·OH radical scavengers , 1977, FEBS letters.

[560]  H. Rasmussen,et al.  Relationships between calcium and cyclic nucleotides in cell activation. , 1977, Physiological reviews.

[561]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[562]  B. Chance,et al.  Properties of glutathione release observed during reduction of organic hydroperoxide, demethylation of aminopyrine and oxidation of some substances in perfused rat liver, and their implications for the physiological function of catalase. , 1977, The Biochemical journal.

[563]  F. Owen,et al.  Dopamine is a monoamine oxidase B substrate in man , 1977, Nature.

[564]  H. Ganther,et al.  SELENIUM AND GLUTATHIONE PEROXIDASE IN DEVELOPING RAT BRAIN 1 , 1976, Journal of neurochemistry.

[565]  E. Holtzman,et al.  Microperoxisome distribution in the central nervous system of the rat , 1976, Brain Research.

[566]  T. N. Thomas,et al.  Distribution of superoxide dismutase in rat brain , 1976, Journal of neurochemistry.

[567]  E. Cadenas,et al.  Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. , 1976, The Biochemical journal.

[568]  J. Brody,et al.  Familial motor neuron disease , 1976, Neurology.

[569]  C. Duve,et al.  SUBCELLULAR DISTRIBUTION OF d‐AMINO ACID OXIDASE AND CATALASE IN RAT BRAIN , 1976, Journal of neurochemistry.

[570]  W. Whelihan,et al.  Levodopa and psychometric test performance in parkinsonism–5 years later , 1976, Neurology.

[571]  B. Bielski,et al.  SOME PROPERTIES OF THE ASCORBATE FREE RADICAL * , 1975, Annals of the New York Academy of Sciences.

[572]  T. Iyanagi,et al.  Relation between redox potentials and rate constants in reactions coupled with the system oxygen-superoxide. , 1975, Biochemistry.

[573]  P. Baudhuin,et al.  Subcellular localization of superoxide dismutase in rat liver. , 1975, The Biochemical journal.

[574]  G. Curzon,et al.  MELANIN FORMATION BY HUMAN BRAIN IN VITRO , 1975, Journal of neurochemistry.

[575]  J. Fishman,et al.  Catechol estrogen formation in the central nervous system of the rat. , 1975, Endocrinology.

[576]  D. Tyler.  Role of superoxide radicals in the lipid peroxidation of intracellular membranes , 1975, FEBS letters.

[577]  M. V. Van Woert,et al.  Brain peroxidase and catalase in Parkinson disease. , 1975, Archives of neurology.

[578]  S. Sligar,et al.  Superoxide anion production by the autoxidation of cytochrome P450cam. , 1974, Biochemical and biophysical research communications.

[579]  P. Strittmatter,et al.  Purification and properties of rat liver microsomal stearyl coenzyme A desaturase. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[580]  M. Sorgato,et al.  Oxygen radicals and hydrogen peroxide in rat brain mitochondria , 1974, FEBS letters.

[581]  R. Hill,et al.  Sequence homologies among bacterial and mitochondrial superoxide dismutases. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[582]  I. Fridovich,et al.  An iron-containing superoxide dismutase from Escherichia coli. , 1973, The Journal of biological chemistry.

[583]  B Chance,et al.  The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. , 1973, The Biochemical journal.

[584]  H. F. Deutsch,et al.  The levels of superoxide dismutase and catalase in human tissues as determined immunochemically. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[585]  L. Flohé,et al.  Glutathione peroxidase: A selenoenzyme , 1973, FEBS letters.

[586]  K. J. Stone,et al.  The effect of L-ascorbate on catecholamine biosynthesis. , 1973, The Biochemical journal.

[587]  H. Ganther,et al.  Selenium: Biochemical Role as a Component of Glutathione Peroxidase , 1973, Science.

[588]  P. Seeman,et al.  The membrane actions of anesthetics and tranquilizers. , 1972, Pharmacological reviews.

[589]  J. Lucy.  FUNCTIONAL and STRUCTURAL ASPECTS OF BIOLOGICAL MEMBRANES: A SUGGESTED STRUCTURAL ROLE FOR VITAMIN E IN THE CONTROL OF MEMBRANE PERMEABILITY and STABILITY , 1972, Annals of the New York Academy of Sciences.

[590]  B Chance,et al.  The cellular production of hydrogen peroxide. , 1972, The Biochemical journal.

[591]  S. Aust,et al.  Evidence for superoxide generation by NADPH-cytochrome c reductase of rat liver microsomes. , 1972, Biochemical and biophysical research communications.

[592]  H Breuer,et al.  Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the ctechol-O-methyltransferases of human liver. , 1972, The Journal of clinical endocrinology and metabolism.

[593]  J. Pincus.  Subacute Necrotizing Encephalomyelopathy (Leigh's Disease): a Consideration of Clinical Features and Etiology , 1972, Developmental medicine and child neurology.

[594]  J. Davis,et al.  Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets. , 1971, Archives of general psychiatry.

[595]  I. Fridovich,et al.  Superoxide dismutase from escherichia coli B. A new manganese-containing enzyme. , 1970, The Journal of biological chemistry.

[596]  I. Fridovich,et al.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.

[597]  S. Nakamura,et al.  One-electron transfer reactions in biochemical systems. IV. A mixed mechanism in the reaction of milk xanthine oxidase with electron acceptors. , 1969, Biochimica et biophysica acta.

[598]  H. Barden.  THE HISTOCHEMICAL RELATIONSHIP OF NEUROMELANIN AND LIPOFUSCIN , 1969, Journal of neuropathology and experimental neurology.

[599]  G. Johnston,et al.  THE OXIDATION OF GLYCINE BY d‐AMINO ACID OXIDASE IN EXTRACTS OF MAMMALIAN CENTRAL NERVOUS TISSUE , 1969, Journal of neurochemistry.

[600]  J. P. Johnston.  Some observations upon a new inhibitor of monoamine oxidase in brain tissue. , 1968, Biochemical pharmacology.

[601]  T. Creighton.  Methods in Enzymology , 1968, The Yale Journal of Biology and Medicine.

[602]  K. Tipton.  The sub-mitochondrial localization of monoamine oxidase in rat liver and brain. , 1967, Biochimica et biophysica acta.

[603]  R. S. Snider,et al.  NEUROPHYSIOLOGY , 1921, Insect Physiology and Biochemistry.

[604]  K. Prasad,et al.  SPECTROSCOPIC STUDIES OF SUBSTANTIA NIGRA PIGMENT IN HUMAN SUBJECTS * , 1967, Journal of neurochemistry.

[605]  A. Tappel,et al.  The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. , 1966, The Journal of biological chemistry.

[606]  E. Wills.  Mechanisms of lipid peroxide formation in animal tissues. , 1966, The Biochemical journal.

[607]  M. Karnovsky,et al.  THE HISTOCHEMICAL DEMONSTRATION OF MONOAMINE OXIDASE ACTIVITY BY COUPLED PEROXIDATIC OXIDATION , 1965, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[608]  R. Katzman.,et al.  CHEMICAL STUDIES ON ALZHEIMER'S DISEASE , 1965, Journal of neuropathology and experimental neurology.

[609]  P. Roe.  Familial motor neurone disease , 1964, Journal of neurology, neurosurgery, and psychiatry.

[610]  P. Hochstein,et al.  GLUTATHIONE PEROXIDASE: THE PRIMARY AGENT FOR THE ELIMINATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES. , 1963, Biochemistry.

[611]  J. Foley,et al.  ON THE NATURE OF PIGMENT GRANULES IN THE CELLS OF THE LOCUS COERULEUS AND SUBSTANTIA NIGRA , 1958, Journal of neuropathology and experimental neurology.

[612]  G. Glenner,et al.  THE HISTOCHEMICAL DEMONSTRATION OF MONOAMINE OXIDASE ACTIVITY BY TETRAZOLIUM SALTS , 1957, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[613]  T. Fitzpatrick,et al.  Mammalian tyrosinase; preparation and properties. , 1949, The Journal of biological chemistry.

[614]  H. Blaschko,et al.  The inactivation of adrenaline , 1937, The Journal of physiology.

[615]  P. James.  An Essay on the Shaking Palsy , 1817, The Medico-Chirurgical Journal and Review.

[616]  B. Zimmermann,et al.  Cellular and Subcellular Targets of Neurotoxins: The Concept of Selective Vulnerability , 1994 .

[617]  S. Younkin,et al.  Molecular biology of Alzheimer's disease. , 1993, Molecular genetic medicine.

[618]  H. Braak,et al.  Anatomy of the Human Basal Ganglia , 1993 .

[619]  D. Reif,et al.  Ferritin as a source of iron for oxidative damage. , 1992, Free radical biology & medicine.

[620]  E. Hall.  Novel inhibitors of iron‐dependent lipid peroxidation for neurodegenerative disorders , 1992, Annals of neurology.

[621]  C. Marsden,et al.  Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia , 1992 .

[622]  A. Whitwood,et al.  An E.S.R. investigation of the reactive intermediate generated in the reaction between FeII and H2O2 in aqueous solution. Direct evidence for the formation of the hydroxyl radical. , 1992, Free radical research communications.

[623]  E. Hirsch.  Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? , 1992, Annals of neurology.

[624]  M. Egan,et al.  Treatment of tardive dyskinesia with vitamin E. , 1992, The American journal of psychiatry.

[625]  T. Chase,et al.  Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease , 1992, Movement disorders : official journal of the Movement Disorder Society.

[626]  A. Whitwood,et al.  Nucleophilic substitution reactions of spin adducts. Implications for the correct identification of reaction intermediates by EPR/spin trapping , 1992 .

[627]  D. Perl,et al.  Comparative techniques for determining cellular iron distribution in brain tissues , 1992, Annals of neurology.

[628]  S. Uhlig,et al.  The physiological consequences of glutathione variations. , 1992, Life sciences.

[629]  G. Nisticó,et al.  NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. , 1992, Free radical biology & medicine.

[630]  C. Marsden,et al.  Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease , 1992, Annals of neurology.

[631]  S. Gershon,et al.  The Cholinergic Model of Dementia, Alzheimer Type: Progression from the Unitary Transmitter Concept , 1992 .

[632]  K. Frenkel.  Carcinogen-mediated oxidant formation and oxidative DNA damage. , 1992, Pharmacology & therapeutics.

[633]  C. Morris,et al.  Histochemical distribution of non-haem iron in the human brain. , 1992, Acta anatomica.

[634]  J. Lucas,et al.  Studies of the mechanism of iron transport across the blood‐brain barrier , 1992, Annals of neurology.

[635]  J. Morris,et al.  Tyrosine hydroxylase-like (TH) immunoreactivity in Parkinson's disease and Alzheimer's disease , 1992, Journal of neural transmission. Parkinson's disease and dementia section.

[636]  D. Brooks,et al.  In vivo and in vitro studies of the dopaminergic system in movement disorders. , 1992, Cerebrovascular and brain metabolism reviews.

[637]  K. Stolze,et al.  Ubisemiquinones of the mitochondrial respiratory chain do not interact with molecular oxygen. , 1992, Free radical research communications.

[638]  K. Jellinger,et al.  Susceptibility of Brains from Patients with Alzheimer's Disease to Oxygen-Stimulated Lipid Peroxidation and Differential Scanning Calorimetry , 1992 .

[639]  B. Halliwell,et al.  The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. , 1992, Free radical research communications.

[640]  I. Date,et al.  Age‐related decline in the dopaminergic nigrostriatal system: The oxidative hypothesis and protective strategies , 1992, Annals of neurology.

[641]  R. J. Coleman.  Current drug therapy for Parkinson's disease. A review. , 1992, Drugs & aging.

[642]  M. Carrillo,et al.  The ability of (-)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective. , 1992, Life sciences.

[643]  S. Fahn.  A pilot trial of high‐dose alpha‐tocopherol and ascorbate in early Parkinson's disease , 1992, Annals of neurology.

[644]  W. Forbes,et al.  Aluminum and dementia. , 1992, Lancet.

[645]  C. Marsden,et al.  Alpha-tocopherol levels in brain are not altered in Parkinson's disease. , 1992, Annals of neurology.

[646]  H. Yoshino,et al.  Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease , 1992, Journal of neural transmission. Parkinson's disease and dementia section.

[647]  Y. Agid,et al.  Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains. , 1991, Free radical research communications.

[648]  H. P. Monteiro,et al.  Ferritin, lipid peroxidation and redox-cycling xenobiotics. , 1991, Free radical research communications.

[649]  J. Schubert,et al.  Does hydrogen peroxide exist "free" in biological systems? , 1991, Free radical biology & medicine.

[650]  D. Calne.  Neurotoxins and degeneration in the central nervous system. , 1991, Neurotoxicology.

[651]  G. Minotti,et al.  Possible sources of iron for lipid peroxidation. , 1991, Free radical research communications.

[652]  K. Davies,et al.  Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. , 1991, Gerontology.

[653]  S. Wolff,et al.  Protein glycation and oxidative stress in diabetes mellitus and ageing. , 1991, Free radical biology & medicine.

[654]  G. Mammen,et al.  Selegiline , 1991 .

[655]  C. Drevon.  Absorption, transport and metabolism of vitamin E. , 1991, Free radical research communications.

[656]  B. Ames,et al.  Assays for 8-hydroxy-2'-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. , 1991, Free radical biology & medicine.

[657]  R. Roberts,et al.  Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal. , 1991, Free radical biology & medicine.

[658]  C. Marsden,et al.  A clinical and genetic study of familial Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.

[659]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[660]  M. Simic.  DNA damage, environmental toxicants, and rate of aging , 1991 .

[661]  A. Valenzuela,et al.  The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. , 1991, Life sciences.

[662]  P. Riederer,et al.  Iron in brain function and dysfunction with emphasis on Parkinson's disease. , 1991, European neurology.

[663]  N. Krinsky,et al.  Characterization of products formed during the autoxidation of β-carotene , 1991 .

[664]  S. Mera.  Aluminium, amyloid, and Alzheimer's disease. , 1991, Medical laboratory sciences.

[665]  Y. Mizoi,et al.  Determination of β-carbolines in foodstuffs by high-performance liquid chromatography and high-performance liquid chromatography-mass spectrometry , 1991 .

[666]  P. Riederer,et al.  Anatomische, biochemische und funktionelle Strukturen physiologischer Neurotransmitter-Regelkreise , 1991 .

[667]  H. Przuntek,et al.  Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: Preliminary observations , 1991, Journal of neural transmission. Parkinson's disease and dementia section.

[668]  P. O'Brien.  Molecular mechanisms of quinone cytotoxicity. , 1991, Chemico-biological interactions.

[669]  A. Meister.  Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. , 1991, Pharmacology & therapeutics.

[670]  W. Lukiw,et al.  WOULD DECREASED ALUMINIUM INGESTION REDUCED THE INCIDENCE OF ALZHEIMER'S DISEASE ? , 1991 .

[671]  M. Ghilardi,et al.  Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates , 1991, Journal of neural transmission. Parkinson's disease and dementia section.

[672]  K. Lange,et al.  Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease , 1991, Journal of neural transmission. Parkinson's disease and dementia section.

[673]  S. Sahu.  Role of oxygen free radicals in the molecular mechanisms of carcinogenesis: A review∗ , 1991 .

[674]  S. Furukawa,et al.  Alpha-tocopherol supports the survival and neurite extension of neurons cultured from various regions of fetal rat brain. , 1991, Neuroscience letters.

[675]  C. Chow.  Vitamin E and oxidative stress. , 1991, Free radical biology & medicine.

[676]  M. Grassi,et al.  Effects of a MAO-B inhibitor in the treatment of Alzheimer disease. , 1991, European neurology.

[677]  W. Pryor,et al.  Noninvasive measures of oxidative stress status in humans. , 1991, Free radical biology & medicine.

[678]  New approaches to the treatment of early Parkinson's disease. , 1991, Acta neurologica Scandinavica. Supplementum.

[679]  F. V. van Kuijk,et al.  Characterization of products formed during the autoxidation of beta-carotene. , 1991, Free radical biology & medicine.

[680]  E. Marani,et al.  Aluminium neurotoxicity. , 1991, Progress in histochemistry and cytochemistry.

[681]  L. Schneider,et al.  Nerve Growth Factor and Alzheimer's Disease , 1991, Clinical neuropharmacology.

[682]  H. Heinsen,et al.  Immunofluorescence cytochemistry on thin frozen sections of human substantia nigra for staining of monoamine oxidase A and monoamine oxidase B: a pilot study. , 1990, Journal of neural transmission. Supplementum.

[683]  D. Muller,et al.  Neurochemical, neurophysiological, and neuropathological studies in vitamin E deficiency. , 1990, Critical reviews in neurobiology.

[684]  J. Olney,et al.  Excitotoxic amino acids and neuropsychiatric disorders. , 1990, Annual review of pharmacology and toxicology.

[685]  W. Koppenol.  What is in a name? Rules for radicals. , 1990, Free radical biology & medicine.

[686]  M. Sussman,et al.  Oxygen-derived free radicals in reperfusion injury. , 1990, Methods in enzymology.

[687]  E. Stadtman,et al.  Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. , 1990, Free radical biology & medicine.

[688]  R. Mayeux,et al.  The "serotonin hypothesis" for depression in Parkinson's disease. , 1990, Advances in neurology.

[689]  K. Ingold,et al.  Biokinetics of dietary RRR-alpha-tocopherol in the male guinea pig at three dietary levels of vitamin C and two levels of vitamin E. Evidence that vitamin C does not "spare" vitamin E in vivo. , 1990, Lipids.

[690]  C. Babbs,et al.  Simulation of free radical reactions in biology and medicine: a new two-compartment kinetic model of intracellular lipid peroxidation. , 1990, Free radical biology & medicine.

[691]  A. Schapira,et al.  Mitochondrial DNA analysis in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[692]  H. Esterbauer,et al.  Influence of the lipid peroxidation product 4-hydroxynonenal on human neutrophil migration , 1990 .

[693]  R. E. Beyer.  The participation of coenzyme Q in free radical production and antioxidation. , 1990, Free radical biology & medicine.

[694]  P. Seth,et al.  Cytochrome P-450 Catalyzed Reactions In Brain , 1990 .

[695]  D. Ben-shachar,et al.  Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction. , 1990, Journal of neural transmission. Supplementum.

[696]  L. Horrocks,et al.  Elevated Activities of Lipases and Lysophospholipase in Alzheimer's Disease , 1990 .

[697]  D. Janero,et al.  Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. , 1990, Free radical biology & medicine.

[698]  J. Říčný,et al.  Advances in the biology of cholinergic neurons. , 1990, Advances in neurology.

[699]  J. Shih,et al.  The expression of human MAO-A and B genes. , 1990, Journal of neural transmission. Supplementum.

[700]  A. Brun,et al.  Subcortical pathology of Alzheimer's disease. , 1990, Advances in neurology.

[701]  R. G. Allen,et al.  Excitotoxic disorders. , 1990, Science.

[702]  K. Jellinger,et al.  Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[703]  A. Palmer,et al.  Tacrine in relation to amino acid transmitters in Alzheimer's disease. , 1990, Advances in neurology.

[704]  K. Beyreuther,et al.  Protein abnormalities in neurofibrillary tangles: their relation to the extracellular amyloid deposits of the A4 protein in Alzheimer's disease. , 1990, Advances in neurology.

[705]  W. Pryor,et al.  Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. , 1990, Free radical biology & medicine.

[706]  R. S. Sohal,et al.  Age-related changes in antioxidant enzymes and prooxidant generation in tissues of the rat with special reference to parameters in two insect species. , 1990, Free radical biology & medicine.

[707]  S. Hodge,et al.  Twin studies and the genetics of Parkinson's disease—a reappraisal , 1990, Movement disorders : official journal of the Movement Disorder Society.

[708]  P. Riederer,et al.  The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson's disease. , 1990, Journal of neural transmission. Supplementum.

[709]  J. Watkins,et al.  Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. , 1990, Trends in pharmacological sciences.

[710]  S. Ohta,et al.  Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer. , 1990, Life sciences.

[711]  E. Mimnaugh,et al.  Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors. , 1990, Free radical biology & medicine.

[712]  E. Hall,et al.  Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. , 1989, Free radical biology & medicine.

[713]  C. Cotman,et al.  The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. , 1989, Annual review of pharmacology and toxicology.

[714]  D. Wallace,et al.  Mitochondrial DNA mutations and neuromuscular disease. , 1989, Trends in genetics : TIG.

[715]  H. Gardner.  Oxygen radical chemistry of polyunsaturated fatty acids. , 1989, Free radical biology & medicine.

[716]  R. Sokol,et al.  Vitamin E and neurologic function in man. , 1989, Free radical biology & medicine.

[717]  S. Banni,et al.  Conjugated dienes detected in tissue lipid extracts by second derivative spectrophotometry. , 1989, Free radical biology & medicine.

[718]  J. Knoll,et al.  Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-)deprenyl. , 1989, Life sciences.

[719]  B. Halliwell,et al.  Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? , 1989, Free radical biology & medicine.

[720]  R. Kostrzewa.  Neurotoxins That Affect Central and Peripheral Catecholamine Neurons , 1989 .

[721]  C. Martyn,et al.  Calcium Metabolism in Alzheimer’s Disease , 1989 .

[722]  B. Bacon,et al.  Hepatic injury in chronic iron overload. Role of lipid peroxidation. , 1989, Chemico-biological interactions.

[723]  K. Beyreuther,et al.  Molecular biology of Alzheimer's disease. , 1989, Annual review of biochemistry.

[724]  K. Tipton,et al.  Interactions of monoamine oxidase with substrates and inhibitors , 1989, Medicinal research reviews.

[725]  DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group. , 1989, Archives of neurology.

[726]  S. Orrenius,et al.  Ca2+-activated mechanisms in cell killing. , 1989, Drug metabolism reviews.

[727]  G. Witz.  Biological interactions of α,β-unsaturated aldehydes , 1989 .

[728]  K. Davies,et al.  Macroxyproteinase (M.O.P.): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. , 1989, Free radical biology & medicine.

[729]  E. Porsche-Wiebking.  New n‐methyl‐d‐aspartate antagonists for the treatment of stroke , 1989 .

[730]  G. Powis.  Free radical formation by antitumor quinones. , 1989, Free radical biology & medicine.

[731]  C. Jeandel,et al.  Lipid peroxidation and free radical scavengers in Alzheimer's disease. , 1989, Gerontology.

[732]  J. Kornhuber,et al.  The Role of Dopamine in the Control of Neurobiological Functions , 1989 .

[733]  A. Carlsson,et al.  The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra , 1989, Journal of neural transmission. Parkinson's disease and dementia section.

[734]  J. Krystal,et al.  Psychopharmacology: The Third Generation of Progress , 1989, The Yale Journal of Biology and Medicine.

[735]  R. Duvoisin,et al.  Biochemical Models of Parkinson’s Disease , 1989 .

[736]  E. Mohr,et al.  Dopamine and memory function in Parkinson's disease , 1989, Movement disorders : official journal of the Movement Disorder Society.

[737]  Anthony E. Lang,et al.  Effect of deprenyl on the progression of disability in early Parkinson's disease. , 1989, The New England journal of medicine.

[738]  K. Jellinger.  Pathology of Parkinson’s Syndrome , 1989 .

[739]  Braughler Jm,et al.  The 21-aminosteroid inhibitors of lipid peroxidation: Reactions with lipid peroxyl and phenoxy radicals , 1989 .

[740]  E. Janzen,et al.  Spin trapping: ESR parameters of spin adducts. , 1988, Free radical biology & medicine.

[741]  D. Steinhilber,et al.  L-ascorbic acid modulates 5-lipoxygenase activity in human polymorphonuclear leukocytes. , 1988, International archives of allergy and applied immunology.

[742]  S. Ohta,et al.  Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease. , 1988, Life sciences.

[743]  F. Amenta,et al.  Effect of long-term treatment with acetyl-L-carnitine on structural changes of ageing rat brain. , 1988, Drugs under experimental and clinical research.

[744]  M. Curzio.  Interaction between neutrophils and 4-hydroxyalkenals and consequences on neutrophil motility. , 1988, Free radical research communications.

[745]  F. Amenta,et al.  Effects of long-term Hydergine administration on lipofuscin accumulation in senescent rat brain. , 1988, Gerontology.

[746]  T. Sarna,et al.  The effect of melanin on iron associated decomposition of hydrogen peroxide. , 1988, Free radical biology & medicine.

[747]  H. Wiśniewski,et al.  Current hypotheses of Alzheimer disease neuropathology and dementia , 1988 .

[748]  G. Holstein,et al.  Ultrastructural chemoanatomy of the basal ganglia: an overview. , 1987, Advances in neurology.

[749]  S J Kish,et al.  Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.

[750]  R. Laschi,et al.  Ultrastructural aspects of ageing rat hippocampus and effects of L-acetyl-carnitine treatment. , 1987, Drugs under experimental and clinical research.

[751]  E. Dratz,et al.  A new role for phospholipase A2: protection of membranes from lipid peroxidation damage , 1987 .

[752]  T. Kaneko,et al.  Lethal effects of a linoleic acid hydroperoxide and its autoxidation products, unsaturated aliphatic aldehydes, on human diploid fibroblasts. , 1987, Chemico-biological interactions.

[753]  L. Forno.  The Lewy body in Parkinson's disease. , 1987, Advances in neurology.

[754]  E. Niki.  Interaction of ascorbate and alpha-tocopherol. , 1987, Annals of the New York Academy of Sciences.

[755]  P. Seeman,et al.  Dopamine D2 receptor density in parkinsonian brain is constant for duration of disease, age, and duration of L-dopa therapy. , 1987, Advances in neurology.

[756]  J. Knoll,et al.  R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron. , 1987, Journal of neural transmission. Supplementum.

[757]  R. Duvoisin,et al.  History of parkinsonism. , 1987, Pharmacology & therapeutics.

[758]  R. Bressler,et al.  The pharmacology of carnitine. , 1987, Annual review of pharmacology and toxicology.

[759]  J. McCord.  Oxygen-derived radicals: a link between reperfusion injury and inflammation. , 1987, Federation proceedings.

[760]  A. Barbeau,et al.  Environmental and genetic factors in the etiology of Parkinson's disease. , 1987, Advances in neurology.

[761]  J. Gray,et al.  The neuropsychology of emotion and personality. , 1987 .

[762]  K. Jellinger,et al.  Overview of morphological changes in Parkinson's disease. , 1987, Advances in neurology.

[763]  G. Buettner.  Spin trapping: ESR parameters of spin adducts. , 1987, Free radical biology & medicine.

[764]  R. Floyd,et al.  Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. , 1986, Free radical research communications.

[765]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[766]  C. V. Smith,et al.  Quantitation of lipid peroxidation products by gas chromatography-mass spectrometry. , 1986, Analytical biochemistry.

[767]  E. Perry.  The cholinergic hypothesis--ten years on. , 1986, British medical bulletin.

[768]  A. Bendich,et al.  The antioxidant role of vitamin C , 1986 .

[769]  J. Groves,et al.  Metalloporphyrin Models for Cytochrome P-450 , 1986 .

[770]  W. Poewe,et al.  Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of L-dopa: clinical and pharmacokinetic observations. , 1986, Clinical neuropharmacology.

[771]  D. Bowen,et al.  Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease. , 1986, British medical bulletin.

[772]  T. Nagatsu,et al.  Identification of 5-S- and 2-S-cysteinyldopamine and 5-S-glutathionyldopamine formed from dopamine by high-performance liquid chromatography with electrochemical detection , 1986 .

[773]  M. Roth,et al.  The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer's disease. , 1986, British medical bulletin.

[774]  O. Lindvall,et al.  Neuroanatomical aspects of neurotransmitters affected in Alzheimer's disease. , 1986, British medical bulletin.

[775]  E. Niki,et al.  Oxidation of a vitamin E model compound, 2,2,5,7,8-pentamethylchroman-6-ol, with the t-butylperoxyl radical , 1986 .

[776]  W. Pryor.  Oxy-radicals and related species: their formation, lifetimes, and reactions. , 1986, Annual review of physiology.

[777]  R. Perry.  Recent advances in neuropathology. , 1986, British medical bulletin.

[778]  A. Girotti.  Mechanisms of lipid peroxidation. , 1985, Journal of free radicals in biology & medicine.

[779]  A. Sevanian,et al.  Phospholiphase A2 dependent release of fatty acids from peroxidized membranes , 1985 .

[780]  W. Pond,et al.  Response to dietary supplementation of vitamin C and vitamin E in weanling pigs fed low vitamin E-selenium diets , 1985 .

[781]  I. Hanbauer,et al.  Role of Calmodulin in the Regulation of Neuronal Function , 1985 .

[782]  R. Denney,et al.  An update on the identity crisis of monoamine oxidase: new and old evidence for the independence of MAO A and B. , 1985, Pharmacology & therapeutics.

[783]  P. McCay.  Vitamin E: interactions with free radicals and ascorbate. , 1985, Annual review of nutrition.

[784]  M. Youdim.  Brain Iron Metabolism Biochemical and Behavioral Aspects Relation to Dopaminergic Neurotransmission , 1985 .

[785]  M. Depew,et al.  Contributions of electron spin resonance spectroscopy to the study of vitamins C, E and K , 1985 .

[786]  H. Kappus.  12 – Lipid Peroxidation: Mechanisms, Analysis, Enzymology and Biological Relevance , 1985 .

[787]  R. Anderson,et al.  The immunostimulatory, antiinflammatory and anti-allergic properties of ascorbate. , 1984, Advances in nutritional research.

[788]  K. Jellinger,et al.  Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity. , 1984, Advances in neurology.

[789]  F. Ursini,et al.  Formation of alpha-tocopherol radical and recycling of alpha-tocopherol by ascorbate during peroxidation of phosphatidylcholine liposomes. An electron paramagnetic resonance study. , 1984, Biochimica et biophysica acta.

[790]  L. Frattola,et al.  Double‐blind evaluation of monosialoganglioside (GM1) therapy in stroke , 1984, Journal of neuroscience research.

[791]  R. Ledeen.  Biology of gangliosides: Neuritogenic and neuronotrophic properties , 1984, Journal of neuroscience research.

[792]  B. Testa,et al.  Xenobiotic metabolism by brain monooxygenases and other cerebral enzymes , 1984 .

[793]  G. Cohen.  Catalase, Glutathione Peroxidase, Superoxide Dismutase, and Cytochrome P-450 , 1983 .

[794]  G. Cohen.  The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. , 1983, Journal of neural transmission. Supplementum.

[795]  G. Fritsma.  Vitamin E and autoxidation. , 1983, The American journal of medical technology.

[796]  D. E. Cebelli.  Kinetics and mechanism for the oxidation of ascorbic acid/ascorbate by HO_2/O_2-radicals. A pulse radiolysis and stopped-flow photolysis study. , 1983 .

[797]  C. Marsden.  Neuromelanin and Parkinson's disease. , 1983, Journal of neural transmission. Supplementum.

[798]  H. Forman,et al.  CHAPTER 3 – Superoxide Radical and Hydrogen Peroxide in Mitochondria , 1982 .

[799]  L. Lewin,et al.  Measurement of carnitine and O-acylcarnitines. , 1981, Methods in enzymology.

[800]  L. Lewin,et al.  [13] Measurement of carnitine and O-acylcarnitines , 1981 .

[801]  H. Mukhtar,et al.  Characterization of microsomal aryl hydrocarbon hydroxylase of rat brain. , 1981, The Journal of pharmacology and experimental therapeutics.

[802]  J. Elsworth,et al.  Dopamine oxidation and its inhibition by (-)-deprenyl in man. , 1980, Journal of neural transmission. Supplementum.

[803]  R. Jeffcoat.  The biosynthesis of unsaturated fatty acids and its control in mammalian liver. , 1979, Essays in biochemistry.

[804]  K. Magyar,et al.  Novel (-)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action. , 1978, Biochemical pharmacology.

[805]  P. Mcgeer,et al.  Aging and extrapyramidal function. , 1977, Archives of neurology.

[806]  C. Masters,et al.  The metabolic roles of peroxisomes in mammalian tissues , 1977 .

[807]  J. Depierre,et al.  Enzyme topology of intracellular membranes. , 1977, Annual review of biochemistry.

[808]  P. Glees,et al.  Lipofuscin in neuronal aging and diseases. , 1976, Normale und pathologische Anatomie.

[809]  R Llinás,et al.  Calcium role in depolarization-secretion coupling: an aequorin study in squid giant synapse. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[810]  M. Berridge.  The interaction of cyclic nucleotides and calcium in the control of cellular activity. , 1975, Advances in cyclic nucleotide research.

[811]  I. Fridovich,et al.  Superoxide dismutases. , 1975, Annual review of biochemistry.

[812]  F. Naftolin,et al.  Conversion of androstenedione to estrone by neural tissues from fetal and neonatal rats. , 1974, Endocrinology.

[813]  E. Dooling,et al.  Hallervorden-Spatz syndrome. , 1974, Archives of neurology.

[814]  P. Yates,et al.  Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. , 1974, Brain : a journal of neurology.

[815]  J. Mead,et al.  Uptake and transport of fatty acids into the brain and the role of the blood-brain barrier system. , 1973, Advances in lipid research.

[816]  A. Tappel.  Lipid peroxidation damage to cell components. , 1973, Federation proceedings.

[817]  H. Thoenen,et al.  The pharmacology of 6-hydroxydopamine. , 1973, Annual Review of Pharmacology.

[818]  K. Magyar,et al.  Some puzzling pharmacological effects of monoamine oxidase inhibitors. , 1972, Advances in biochemical psychopharmacology.

[819]  U. Brunk,et al.  Electron microscopical studies on rat brain neurons. Localization of acid phosphatase and mode of formation of lipofuscin bodies. , 1972, Journal of ultrastructure research.

[820]  J. Rybakowski.  [The role of brain dopamine]. , 1972, Psychiatria polska.

[821]  F. Andermann,et al.  Subacute necrotizing encephalomyelopathy. A review and a study of two families. , 1971, Brain : a journal of neurology.

[822]  S. Kety,et al.  The circulation and energy metabolism of the brain. , 1963, Clinical neurosurgery.

[823]  R. Lillie,et al.  Histochemical Studies on the Neuromelanins , 1960 .

[824]  R. Lillie,et al.  On the Yellow Brown Pigments of the Substantia Nigra, Locus Caeruleus and Dorsal Vagus Nucleus of a Monkey (Macaca Mulatta) , 1960 .

[825]  S. Bouisset,et al.  [Voluntary movement]. , 1953, Journal de physiologie.

[826]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .

[827]  H. Fenton,et al.  LXXIII.—Oxidation of tartaric acid in presence of iron , 1894 .